Citations

Citations to this article as recorded by  

• Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1
  Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim
  Inflammatory Bowel Diseases.2023; 29(2): 238.     CrossRef
• Histologic Activity and Steroid Use History are Risk Factors of Clinical Relapse in Ulcerative Colitis with Endoscopic Remission
  Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• Altered Structural Expression and Enzymatic Activity Parameters in Quiescent Ulcerative Colitis: Are These Potential Normalization Criteria?
  Sebastian Kjærgaard, Morten M. B. Damm, Joan Chang, Lene B. Riis, Hanne B. Rasmussen, Rasmus Hytting-Andreasen, Susanne M. Krug, Jörg-Dieter Schulzke, Niels Bindslev, Mark Berner Hansen
  International Journal of Molecular Sciences.2020; 21(5): 1887.     CrossRef

Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in this region. Thus, the Asian Organization for Crohn's and Colitis and the Asia Pacific Association of Gastroenterology have developed a set of consensus statements about risk assessment, detection and prevention of latent TB infection, and management of active TB infection in patients with inflammatory bowel disease (IBD) receiving anti-TNF treatment. Twenty-three consensus statements were initially drafted and then discussed by the committee members. The quality of evidence and the strength of recommendations were assessed by using the Grading of Recommendations Assessment, Development, and Evaluation methodology. Web-based consensus voting was performed by 211 IBD specialists from 9 Asian countries concerning each statement. A consensus statement was accepted if at least 75% of the participants agreed. Part 1 of the statements comprised 2 parts: risk of TB infection Recommendaduring anti-TNF therapy, and screening for TB infection prior to commencing anti-TNF therapy. These consensus statements will help clinicians optimize patient outcomes by reducing the morbidity and mortality related to TB infections in patients with IBD receiving anti-TNF treatment.

Citations

Citations to this article as recorded by  

• Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn’s Disease on Ustekinumab: A Nationwide Real-World Study
  Rongbei Liu, Zhilun Li, Lingna Ye, Jing Hu, Jian Tang, Baili Chen, Xiuli Chen, Bei Tan, Yubei Gu, Chen Xie, Chunhui Ouyang, Xiaomei Song, Fan Li, Yanyun Fan, Haixia Ren, Liangru Zhu, Min Chen, Wenyu Jiang, Qian Cao
  Inflammatory Bowel Diseases.2024; 30(1): 45.     CrossRef
• (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review
  Thomas Theo Brehm, Maja Reimann, Niklas Köhler, Christoph Lange
  Clinical Microbiology and Infection.2024; 30(8): 989.     CrossRef
• Ten missteps in the management of inflammatory bowel disease in Asia: An expert report by the Asian Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease
  Vineet Ahuja, Ida Hilmi, Byong Duk Ye, Khoon Lin Ling, Siew C. Ng, Rupert W. Leong, Peeyush Kumar, Xin Hui Khoo, Govind K. Makharia, Jose Sollano, Pises Pisespongsa, Nazri Mustaffa, Rupa Banerjee, Alex Hwong‐Ruey Leow, Raja Affendi Raja Ali, Sai Wei Chuah
  Journal of Gastroenterology and Hepatology.2024; 39(8): 1500.     CrossRef
• Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
  Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim
  Intestinal Research.2023; 21(1): 61.     CrossRef
• Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients
  Flora Maria Lorenzo Fortes, Raquel Rocha, Genoile Oliveira Santana
  World Journal of Gastroenterology.2023; 29(9): 1536.     CrossRef
• Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy
  Kyunghwan Oh, Kee Don Choi, Hyeong Ryul Kim, Tae Sun Shim, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park
  Clinical Endoscopy.2023; 56(2): 239.     CrossRef
• Miliary Tuberculosis in a Patient With Ulcerative Colitis Treated With Tofacitinib
  Shruti Verma, Arshdeep Singh, Chandan Kakkar, Ashish Tripathi, Vandana Midha, Ajit Sood
  ACG Case Reports Journal.2023; 10(6): e01066.     CrossRef
• Intestinal tuberculosis can masquerade as Crohn’s disease: A teachable moment
  Pooja KC, Madhur Bhattarai, Subodh Adhikari, Prakriti Parajuli, Sujata Bhandari, Himal Bikram Bhattarai, Niraj Kumar Sharma, Shailendra Karki, Suryakiran Acharya, Bibhusan Basnet
  SAGE Open Medical Case Reports.2023;[Epub]     CrossRef
• The safety of vedolizumab in a patient with Crohn’s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report
  Yuya Sugiyama, Nobuhiro Ueno, Shion Tachibana, Yu Kobayashi, Yuki Murakami, Takahiro Sasaki, Aki Sakatani, Keitaro Takahashi, Katsuyoshi Ando, Shin Kashima, Kentaro Moriichi, Hiroki Tanabe, Toshikatsu Okumura, Mikihiro Fujiya
  Medicine.2023; 102(28): e34331.     CrossRef
• Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Analysis
  Sayan Malakar, Srikanth Kothalkar, Umair Shamsul Hoda, Uday C Ghoshal
  Cureus.2023;[Epub]     CrossRef
• Crohn’s disease and intestinal tuberculosis: challenging from every angle
  Andreia Guimarães, João Gama, Luis Curvo-Semedo, António Canaveira Manso
  BMJ Case Reports.2023; 16(12): e254400.     CrossRef
• Development of Spinal Tuberculosis in an Adolescent With Crohn's Disease After Infliximab Therapy: A Case Report With Literature Review
  Jae Hoon Jung, Sujin Choi, Youra Kang, Dae-Chul Cho, So Mi Lee, Tae In Park, Byung-Ho Choe, Dongsub Kim, Ben Kang
  Frontiers in Pediatrics.2022;[Epub]     CrossRef
• Increased Risk of Infection With High Infliximab Trough Level
  Suprabhat Giri, Harish Darak
  Journal of Clinical Gastroenterology.2022; 56(4): 374.     CrossRef
• Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
  Chan Hyuk Park, Jung Ho Park, Yoon Suk Jung
  Journal of Personalized Medicine.2022; 12(3): 507.     CrossRef
• Evidence-Based Commentary: Testing and Treating Latent Tuberculosis Before Starting Biologics and Small Molecules in Patients with Inflammatory Bowel Disease
  Rinkalben Kakadiya, Vishal Sharma
  Journal of Gastrointestinal Infections.2022; 12(02): 128.     CrossRef
• Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors
  Kyuwon Kim, Kyung-Wook Jo, Tae Sun Shim, Jin Hwa Park, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
  Sujin Choi, Bong Seok Choi, Byung-Ho Choe, Ben Kang
  Yeungnam University Journal of Medicine.2021; 38(3): 251.     CrossRef
• Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
  Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi
  Intestinal Research.2021; 19(4): 419.     CrossRef
• Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti‐TNF therapy in a tuberculosis endemic region
  Lingna Ye, Thomas P. Chapman, Zhenzhen Wen, Lang Lin, Yun Qiu, Zhanju Liu, Zhihua Ran, Jiaming Qian, Kaichun Wu, Xiang Gao, Pinjin Hu, Minhu Chen, Simon P. L. Travis, Qian Cao
  Alimentary Pharmacology & Therapeutics.2021; 53(3): 390.     CrossRef
• Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
  Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
  Gut and Liver.2020; 14(6): 685.     CrossRef
• Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Hosim Soh, Jaeyoung Chun, Kyungdo Han, Seona Park, Gukhwan Choi, Jihye Kim, Jooyoung Lee, Jong Pil Im, Joo Sung Kim
  Gut and Liver.2019; 13(3): 333.     CrossRef
• Screening for latent tuberculosis in patients with inflammatory bowel disease under antitumor necrosis factor: data from a Portuguese center
  Mafalda Sousa, Inês Ladeira, Ana Ponte, Carlos Fernandes, Adélia Rodrigues, Ana P. Silva, João Silva, Catarina Gomes, Edgar Afeto, João Carvalho
  European Journal of Gastroenterology & Hepatology.2019; 31(9): 1099.     CrossRef
• The Use of Biologics and Biosimilar in Asian patients with IBD: Are we ready?
  Joyce WY Mak, Joseph JY Sung
  Journal of Gastroenterology and Hepatology.2019; 34(8): 1269.     CrossRef
• Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease
  Youn I Choi, Tae Jun Kim, Dong Kyun Park, Jun-won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim
  International Journal of Colorectal Disease.2019; 34(10): 1713.     CrossRef
• Multidrug-resistant Disseminated Tuberculosis Related to Infliximab in a Patient with Ulcerative Colitis and Negative Evaluation for Latent Tuberculosis
  Yu Kyung Jun, Jaeyoung Chun, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim
  The Korean Journal of Gastroenterology.2019; 74(3): 168.     CrossRef
• Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
  
  Intestinal Research.2018; 16(2): 178.     CrossRef
• High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
  Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja
  Intestinal Research.2018; 16(4): 588.     CrossRef
• Risk of infection associated with anti-TNF-α therapy
  Mario Fernández-Ruiz, José María Aguado
  Expert Review of Anti-infective Therapy.2018; 16(12): 939.     CrossRef

Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in this region. Thus, the Asian Organization for Crohn's and Colitis and the Asia Pacific Association of Gastroenterology have developed a set of consensus statements about risk assessment, detection and prevention of latent TB infection, and management of active TB infection in patients with inflammatory bowel disease (IBD) receiving anti-TNF treatment. Twenty-three consensus statements were initially drafted and then discussed by the committee members. The quality of evidence and the strength of recommendations were assessed by using the Grading of Recommendations Assessment, Development, and Evaluation methodology. Web-based consensus voting was performed by 211 IBD specialists from 9 Asian countries concerning each statement. A consensus statement was accepted if at least 75% of the participants agreed. Part 2 of the statements comprised 3 parts: management of latent TB in preparation for anti-TNF therapy, monitoring during anti-TNF therapy, and management of an active TB infection after anti-TNF therapy. These consensus statements will help clinicians optimize patient outcomes by reducing the morbidity and mortality related to TB infections in patients with IBD receiving anti-TNF treatment.

Citations

Citations to this article as recorded by  

• Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn’s Disease on Ustekinumab: A Nationwide Real-World Study
  Rongbei Liu, Zhilun Li, Lingna Ye, Jing Hu, Jian Tang, Baili Chen, Xiuli Chen, Bei Tan, Yubei Gu, Chen Xie, Chunhui Ouyang, Xiaomei Song, Fan Li, Yanyun Fan, Haixia Ren, Liangru Zhu, Min Chen, Wenyu Jiang, Qian Cao
  Inflammatory Bowel Diseases.2024; 30(1): 45.     CrossRef
• Medical management of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group
  Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen S. C. Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw
  Journal of Gastroenterology and Hepatology.2023; 38(4): 523.     CrossRef
• Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
  Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim
  Intestinal Research.2023; 21(1): 61.     CrossRef
• Miliary Tuberculosis in a Patient With Ulcerative Colitis Treated With Tofacitinib
  Shruti Verma, Arshdeep Singh, Chandan Kakkar, Ashish Tripathi, Vandana Midha, Ajit Sood
  ACG Case Reports Journal.2023; 10(6): e01066.     CrossRef
• IBD barriers across the continents – East Asia
  Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Development of Spinal Tuberculosis in an Adolescent With Crohn's Disease After Infliximab Therapy: A Case Report With Literature Review
  Jae Hoon Jung, Sujin Choi, Youra Kang, Dae-Chul Cho, So Mi Lee, Tae In Park, Byung-Ho Choe, Dongsub Kim, Ben Kang
  Frontiers in Pediatrics.2022;[Epub]     CrossRef
• A case of paradoxical response during anti-tuberculosis treatment in a patient with ulcerative colitis
  Shuhei Hosomi, Naoko Sugita, Atsushi Kanamori, Masaki Ominami, Koji Otani, Noriko Kamata, Fumio Tanaka, Yasuaki Nagami, Koichi Taira, Yasuhiro Fujiwara
  Clinical Journal of Gastroenterology.2022; 15(3): 592.     CrossRef
• Prophylactic Antitubercular Therapy Is Associated With Accelerated Disease Progression in Patients With Crohn's Disease Receiving Anti-TNF Therapy: A Retrospective Multicenter Study
  Fen Liu, Jian Tang, Lingna Ye, Jinyu Tan, Yun Qiu, Fan Hu, Jinshen He, Baili Chen, Yao He, Zhirong Zeng, Ren Mao, Qian Cao, Xiang Gao, Minhu Chen
  Clinical and Translational Gastroenterology.2022; 13(6): e00493.     CrossRef
• Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
  Sujin Choi, Bong Seok Choi, Byung-Ho Choe, Ben Kang
  Yeungnam University Journal of Medicine.2021; 38(3): 251.     CrossRef
• Current status of inflammatory bowel diseases in Korea
  Suk-Kyun Yang
  Journal of the Korean Medical Association.2021; 64(9): 572.     CrossRef
• Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
  Yunho Jung
  The Korean Journal of Gastroenterology.2020; 75(1): 1.     CrossRef
• Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy
  Jihye Kim, Jong Pil Im, Jae-Joon Yim, Chang Kyun Lee, Dong Il Park, Chang Soo Eun, Sung-Ae Jung, Jeong Eun Shin, Kang-Moon Lee, Jae Hee Cheon
  The Korean Journal of Gastroenterology.2020; 75(1): 29.     CrossRef
• Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI: A cohort study
  Xiaolong Ge, Huaying Liu, Shasha Tang, Yan Wu, Yipeng Pan, Wei Liu, Weilin Qi, Lingna Ye, Qian Cao, Wei Zhou
  International Journal of Surgery.2020; 79: 294.     CrossRef
• Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
  Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
  Gut and Liver.2020; 14(6): 685.     CrossRef
• Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease
  Youn I Choi, Tae Jun Kim, Dong Kyun Park, Jun-won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim
  International Journal of Colorectal Disease.2019; 34(10): 1713.     CrossRef
• Translating the gut microbiome: ready for the clinic?
  Susan V. Lynch, Siew C. Ng, Fergus Shanahan, Herbert Tilg
  Nature Reviews Gastroenterology & Hepatology.2019; 16(11): 656.     CrossRef
• Multidrug-resistant Disseminated Tuberculosis Related to Infliximab in a Patient with Ulcerative Colitis and Negative Evaluation for Latent Tuberculosis
  Yu Kyung Jun, Jaeyoung Chun, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim
  The Korean Journal of Gastroenterology.2019; 74(3): 168.     CrossRef
• Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
  
  Intestinal Research.2018; 16(2): 178.     CrossRef
• A rare case of disseminated histoplasmosis in a patient with Crohn’s disease on immunosuppressive treatment
  Bhavesh Bhut, Akshay Kulkarni, Varnika Rai, Vinita Agrawal, Abhai Verma, Manoj Jain, Rungmei S K Marak, Ajai Kumar Dixit, Uday C Ghoshal
  Indian Journal of Gastroenterology.2018; 37(5): 472.     CrossRef
• High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
  Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja
  Intestinal Research.2018; 16(4): 588.     CrossRef

Inflammatory bowel disease (IBD) is a chronic inflammatory state of the gastrointestinal tract and can be classified into 2 main clinical phenomena: Crohn's disease (CD) and ulcerative colitis (UC). The pathogenesis of IBD, including CD and UC, involves the presence of pathogenic factors such as abnormal gut microbiota, immune response dysregulation, environmental changes, and gene variants. Although many investigations have tried to identify novel pathogenic factors associated with IBD that are related to environmental, genetic, microbial, and immune response factors, a full understanding of IBD pathogenesis is unclear. Thus, IBD treatment is far from optimal, and patient outcomes can be unsatisfactory. As result of massive studying on IBD, T helper 17 (Th17) cells and innate lymphoid cells (ILCs) are investigated on their effects on IBD. A recent study of the plasticity of Th17 cells focused primarily on colitis. ILCs also emerging as novel cell family, which play a role in the pathogenesis of IBD. IBD immunopathogenesis is key to understanding the causes of IBD and can lead to the development of IBD therapies. The aim of this review is to explain the pathogenesis of IBD, with a focus on immunological factors and therapies.

Citations

Citations to this article as recorded by  

• A critical review on inflammatory bowel diseases risk factors, dietary nutrients regulation and protective pathways based on gut microbiota during recent 5 years
  Pengkui Xia, Tao Hou, Hong Jin, Yaqi Meng, Jing Li, Fuchao Zhan, Fang Geng, Bin Li
  Critical Reviews in Food Science and Nutrition.2024; 64(24): 8805.     CrossRef
• Safety and Effectiveness of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
  Dushyant Singh Dahiya, Saurabh Chandan, Jay Bapaye, Babu P. Mohan, Daryl Ramai, Lena L. Kassab, Ojasvini C. Chandan, Parambir S. Dulai, Gursimran S. Kochhar
  Journal of Clinical Gastroenterology.2024; 58(4): 378.     CrossRef
• Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe
  Ran Jin, Chidozie Nduka, Delphine Courmier, Hannah Knight, Rachael Meadows, James Piercy, J. R. F. Cummings, Waldemar Radziszewski
  Advances in Therapy.2024; 41(1): 331.     CrossRef
• Gut-brain axis interacts with immunomodulation in inflammatory bowel disease
  Xianglu Ye, Miao Zhang, Ning Zhang, Hai Wei, Bing Wang
  Biochemical Pharmacology.2024; 219: 115949.     CrossRef
• Unraveling the gut-Lung axis: Exploring complex mechanisms in disease interplay
  Mariam Wed Eladham, Balachandar Selvakumar, Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Saleh Mohamed Ibrahim, Rabih Halwani
  Heliyon.2024; 10(1): e24032.     CrossRef
• Gut-on-chip devices as intestinal inflammation models and their future for studying multifactorial diseases
  Susanne Taavitsainen, Kati Juuti-Uusitalo, Kalle Kurppa, Katri Lindfors, Pasi Kallio, Minna Kellomäki
  Frontiers in Lab on a Chip Technologies.2024;[Epub]     CrossRef
• Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directions
  Robert D Little, Thisun Jayawardana, Sabrina Koentgen, Fan Zhang, Susan J Connor, Alex Boussioutas, Mark G Ward, Peter R Gibson, Miles P Sparrow, Georgina L Hold
  eGastroenterology.2024; 2(1): e100006.     CrossRef
• Burden of Anxiety, Depression and Perceived Stress in Patients with Inflammatory Bowel Disease: A Cohort Study from North India
  Arshdeep Singh, Arshia Bhardwaj, Ashish Tripathi, Mukesh Kumar Ranjan, Dharmatma Singh, Ashi Sachdeva, Mahima Marwah, Kriti Sood Sadana, Namita Bansal, Ramit Mahajan, Kirandeep Kaur, Vandana Midha, Ajit Sood
  Digestive Diseases and Sciences.2024; 69(3): 775.     CrossRef
• SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study
  Laura N. Rossier, Natalie P. Décosterd, Christoph B. Matter, Dominic A. Staudenmann, André Moser, Bernhard Egger, Frank W. Seibold
  Annals of Medicine.2024;[Epub]     CrossRef
• Chensinin-1b Alleviates DSS-Induced Inflammatory Bowel Disease by Inducing Macrophage Switching from the M1 to the M2 Phenotype
  Yue Sun, Huiyu Li, Xingpeng Duan, Xiaoxiao Ma, Chenxi Liu, Dejing Shang
  Biomedicines.2024; 12(2): 345.     CrossRef
• Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases
  Neeta Solanki, Gaurav Gupta, Dinesh Kumar Chellappan, Sachin Kumar Singh, Monica Gulati, Keshav Raj Paudel, Philip M Hansbro, Kamal Dua, Suraj Bhan, Manisha Saini, Harish Dureja
  Endocrine, Metabolic & Immune Disorders - Drug Targets.2024; 24(1): 116.     CrossRef
• Exploring Chinese herbal medicine for the treatment of inflammatory bowel disease: A comprehensive overview
  Jeetendra Kumar Gupta, Aniruddh Pratap Singh, Yati Sharma
  Pharmacological Research - Modern Chinese Medicine.2024; 10: 100380.     CrossRef
• Silent information regulator 2 deficiency exacerbates chronic cold exposure-induced colonic injury and p65 activation in mice
  Jingru Guo, Huaixiu Zhang, Huijie Hu, Tianrui Zhao, Hong Ji, Li Ma, Jingjing Lu, Jianbin Yuan, Bin Xu
  Gene.2024; 907: 148276.     CrossRef
• Identified S100A9 as a target for diagnosis and treatment of ulcerative colitis by bioinformatics analysis
  Lulu Tan, Xin Li, Hong Qin, Qingqing Zhang, Jinfeng Wang, Tao Chen, Chengwu Zhang, Xiaoying Zhang, Yuyan Tan
  Scientific Reports.2024;[Epub]     CrossRef
• Design, synthesis, in vitro and in vivo biological evaluation of pterostilbene derivatives for anti-inflammation therapy
  Liuzeng Chen, Ke Wang, Xiaohan Liu, Lifan Wang, Hui Zou, Shuying Hu, Lingling Zhou, Rong Li, Shiying Cao, Banfeng Ruan, Quanren Cui
  Journal of Enzyme Inhibition and Medicinal Chemistry.2024;[Epub]     CrossRef
• Long noncoding RNAs and circular RNAs as potential diagnostic biomarkers of inflammatory bowel diseases: a systematic review and meta-analysis
  Melaku Ashagrie Belete, Selamyhun Tadesse, Mihret Tilahun, Alemu Gedefie, Agumas Shibabaw, Zewudu Mulatie, Muluken Amare Wudu, Saba Gebremichael, Habtu Debash, Mihreteab Alebachew, Ermiyas Alemayehu
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Peripheral and intestinal T lymphocyte subsets in dogs with chronic inflammatory enteropathy
  Beatriz Agulla, Alejandra Villaescusa, Ángel Sainz, David Díaz‐Regañón, Fernando Rodríguez‐Franco, Lydia Calleja‐Bueno, Patricia Olmeda, Mercedes García‐Sancho
  Journal of Veterinary Internal Medicine.2024; 38(3): 1437.     CrossRef
• Review of Animal Models of Colorectal Cancer in Different Carcinogenesis Pathways
  Xue Chen, Yirong Ding, Yun Yi, Zhishan Chen, Jiaping Fu, Ying Chang
  Digestive Diseases and Sciences.2024; 69(5): 1583.     CrossRef
• Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations
  Di Liu, Meiling Cao, Haotian Wang, Weijie Cao, Chenguang Zheng, Yun Li, Youxin Wang
  BMC Medicine.2024;[Epub]     CrossRef
• Effects of Shenling Baizhu Powder on Intestinal Short-Chain Fatty Acid Content and Intestinal Protection in Rats with Inflammatory Bowel Disease
  可心 崔
  Advances in Clinical Medicine.2024; 14(03): 1930.     CrossRef
• Tissue-specific reprogramming leads to angiogenic neutrophil specialization and tumor vascularization in colorectal cancer
  Triet M. Bui, Lenore K. Yalom, Edward Ning, Jessica M. Urbanczyk, Xingsheng Ren, Caroline J. Herrnreiter, Jackson A. Disario, Brian Wray, Matthew J. Schipma, Yuri S. Velichko, David P. Sullivan, Kouki Abe, Shannon M. Lauberth, Guang-Yu Yang, Parambir S. D
  Journal of Clinical Investigation.2024;[Epub]     CrossRef
• Discontinuation of therapy in inflammatory bowel disease: Current views
  Antonio Meštrović, Marko Kumric, Josko Bozic
  World Journal of Clinical Cases.2024; 12(10): 1718.     CrossRef
• Colonic Dysregulation of Major Metabolic Pathways in Experimental Ulcerative Colitis
  Ji Yeon Noh, Naser Farhataziz, Michael T. Kinter, Xin Yan, Yuxiang Sun
  Metabolites.2024; 14(4): 194.     CrossRef
• Cirsimaritin Alleviates Dextran Sodium Sulfate-Induced Acute Colitis in Experimental Animals: A Therapeutic Approach for Inflammatory Bowel Disease
  Abdelrahim Alqudah, Esam Qnais, Omar Gammoh, Yousra Bseiso, Mohammed Wedyan, Mohammad Alqudah, Taher Hatahet
  Preventive Nutrition and Food Science.2024; 29(1): 31.     CrossRef
• Potential shared pathogenic mechanisms between endometriosis and inflammatory bowel disease indicate a strong initial effect of immune factors
  Haolong Zhang, Yaxin Mo, Ling Wang, Haoling Zhang, Sen Wu, Doblin Sandai, Ahmad Naqib Shuid, Xingbei Chen
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity
  Ayman Menesy, Mohamed Hammad, Salah Aref, Fatma Adel Mourad Abozeid
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Pregnancy period and early-life risk factors for inflammatory bowel disease: a Northern Finland birth cohort 1966 study
  Timo M. Blomster, Olli-Pekka Koivurova, Ritva Koskela, Karl-Heinz Herzig, Nicholas J. Talley, Jukka Ronkainen
  BMC Public Health.2024;[Epub]     CrossRef
• Anti-inflammatory and protective effects of Aripiprazole on TNBS-Induced colitis and associated depression in rats: Role of kynurenine pathway
  Afrooz Mohammadgholi-Beiki, Mohammad Sheibani, Majid Jafari-Sabet, Manijeh Motevalian, Parvaneh Rahimi-Moghaddam
  International Immunopharmacology.2024; 133: 112158.     CrossRef
• Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis
  Ganimete Bajraktari, Tanja Elger, Muriel Huss, Johanna Loibl, Andreas Albert, Arne Kandulski, Martina Müller, Hauke Christian Tews, Christa Buechler
  International Journal of Molecular Sciences.2024; 25(9): 4765.     CrossRef
• Take vedolizumab home: transition from intravenous to subcutaneous treatment
  Kaituo Huang, Lingya Yao, Jing Liu, Qian Cao
  Therapeutic Advances in Chronic Disease.2024;[Epub]     CrossRef
• Urinary soluble CD163 is a putative non-invasive biomarker for primary sclerosing cholangitis
  Tanja Elger, Tanja Fererberger, Muriel Huss, Stefanie Sommersberger, Patricia Mester, Petra Stoeckert, Stefan Gunawan, Gerhard Liebisch, Johanna Loibl, Arne Kandulski, Martina Müller, Christa Buechler, Hauke Christian Tews
  Experimental and Molecular Pathology.2024; 137: 104900.     CrossRef
• Bone marrow mesenchymal stromal cells support regeneration of intestinal damage in a colitis mouse model, independent of their CXCR4 expression
  Burcu Pervin, Merve Gizer, Mehmet Emin Şeker, Özgür Doğuş Erol, Sema Nur Gür, Ece Gizem Polat, Bahar Değirmenci, Petek Korkusuz, Fatima Aerts‐Kaya
  Clinical and Translational Science.2024;[Epub]     CrossRef
• Identification and Molecular Mechanism of Anti-inflammatory Peptides Isolated from Jack Bean Protein Hydrolysates: in vitro Studies with Human Intestinal Caco-2BBe Cells
  Bambang Dwi Wijatniko, Yoshinari Yamamoto, Makoto Hirayama, Takuya Suzuki
  Plant Foods for Human Nutrition.2024; 79(3): 624.     CrossRef
• Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease
  Shulin Wei, Mingxing Li, Qin Wang, Yueshui Zhao, Fukuan Du, Yu Chen, Shuai Deng, Jing Shen, Ke Wu, Jiayue Yang, Yuhong Sun, Li Gu, Xiaobing Li, Wanping Li, Meijuan Chen, Xiao Ling, Lei Yu, Zhangang Xiao, Lishu Dong, Xu Wu
  Journal of Inflammation Research.2024; Volume 17: 3307.     CrossRef
• From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases
  Oliviu-Florentiu Sarb, Adriana-Daniela Sarb, Maria Iacobescu, Irina-Maria Vlad, Mircea-Vasile Milaciu, Lorena Ciurmarnean, Vitalie Vacaras, Alina-Ioana Tantau
  International Journal of Molecular Sciences.2024; 25(11): 5676.     CrossRef
• Zinc and Inflammatory Bowel Disease: From Clinical Study to Animal Experiment
  Xi Peng, Yingxiang Yang, Rao Zhong, Yuexuan Yang, Fang Yan, Na Liang, Shibin Yuan
  Biological Trace Element Research.2024;[Epub]     CrossRef
• Impact of high-salt diet in health and diseases and its role in pursuit of cancer immunotherapy by modulating gut microbiome
  Yuvaraj Balan, Raja Sundaramurthy, Archana Gaur, Sakthivadivel Varatharajan, Gerard Marshall Raj
  Journal of Family Medicine and Primary Care.2024; 13(5): 1628.     CrossRef
• Integrated analyses reveal the diagnostic and predictive values of COL5A2 and association with immune environment in Crohn’s disease
  Tingting Zhong, Xiaoqing Cheng, Qianru Gu, Guoxiang Fu, Yihong Wang, Yujie Jiang, Jiaqi Xu, Zhinong Jiang
  Genes & Immunity.2024; 25(3): 209.     CrossRef
• Protection effect of Dioscoreae Rhizoma against ethanol-induced gastric injury in vitro and in vivo: A phytochemical and pharmacological study
  Yujun Xie, Luyao An, Xiaoyan Wang, Yajie Ma, Alamusi Bayoude, Xinxin Fan, Boyang Yu, Renshi Li
  Journal of Ethnopharmacology.2024; 333: 118427.     CrossRef
• Co-delivery of a curcumin and asafoetida as a bioavailable complex using fenugreek galactomannan hydrogel scaffold alleviates inflammatory bowel disease on experimental animals
  Krishnapriya Anil, Svenia P. Jose, Syam Das S, A. Abdul Vahab
  Pharmacological Research - Natural Products.2024; 4: 100071.     CrossRef
• The roles of Th cells in myocardial infarction
  Jun Liu, Feila Liu, Tingting Liang, Yue Zhou, Xiaohan Su, Xue Li, Jiao Zeng, Peng Qu, Yali Wang, Fuli Chen, Qian Lei, Gang Li, Panke Cheng
  Cell Death Discovery.2024;[Epub]     CrossRef
• Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study
  Abigail Gault, Linda Hogarth, Kristian C Williams, Alastair Greystoke, Neil Rajan, Ally Speight, Christopher A Lamb, Alison Bridgewood, Lisa-Jayne Brown-Schofield, Fiona Rayner, John D Isaacs, Jérémie Nsengimana, Christopher J Stewart, Amy E Anderson, Rut
  BMC Cancer.2024;[Epub]     CrossRef
• A comprehensive immunobiology review of IBD: With a specific glance to Th22 lymphocytes development, biology, function, and role in IBD
  Jing Lv, Yousif Saleh Ibrahim, Alexey Yumashev, Ahmed Hjazi, Ali Faraz, Mohammed Jawad Alnajar, Maytham T. Qasim, Pallavi Ghildiyal, Ahmed Hussein Zwamel, Yasser Fakri Mustafa
  International Immunopharmacology.2024; 137: 112486.     CrossRef
• Synbiotics containing sea buckthorn polysaccharides ameliorate DSS-induced colitis in mice via regulating Th17/Treg homeostasis through intestinal microbiota and their production of BA metabolites and SCFAs
  Mingyou Yuan, Lili Chang, Pan Gao, Jing Li, Xinyuan Lu, Mingfang Hua, Xiulian Li, Xuebo Liu, Ying Lan
  International Journal of Biological Macromolecules.2024; 276: 133794.     CrossRef
• FGL2 improves experimental colitis related to gut microbiota structure and bile acid metabolism by regulating macrophage autophagy and apoptosis
  Yuan Zhao, Zheng Xiang, Haoran Pan, Xielin Huang, Weizhen Chen, Zhiming Huang
  Heliyon.2024; 10(14): e34349.     CrossRef
• The emerging role of oxidative stress in inflammatory bowel disease
  Peter Muro, Li Zhang, Shuxuan Li, Zihan Zhao, Tao Jin, Fei Mao, Zhenwei Mao
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Causal relationship between circulating immune cells and inflammatory bowel disease: A Mendelian randomization analysis
  Shan Li, Dujuan Mao, Quanshui Hao, Lijuan You, Xiufang Li, Yaohua Wu, Lai Wei, Heng Du
  Medicine.2024; 103(30): e39056.     CrossRef
• Therapeutic role of extracellular vesicles from human umbilical cord mesenchymal stem cells and their wide therapeutic implications in inflammatory bowel disease and other inflammatory disorder
  Muhammad Azhar Ud Din, Aijun Wan, Ying Chu, Jing Zhou, Yongmin Yan, Zhiliang Xu
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Evaluating the causal effect of circulating proteome on the risk of inflammatory bowel disease-related traits using Mendelian randomization
  Beining Li, Ping Hu, Hongyan Liang, Xingliang Zhao, Aiting Zhang, Yingchong Xu, Bin Zhang, Jie Zhang
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Mucosal Immunity and Trained Innate Immunity of the Gut
  Tsvetelina Velikova, Issa El Kaouri, Konstantina Bakopoulou, Milena Gulinac, Kremena Naydenova, Martin Dimitrov, Milena Peruhova, Snezhina Lazova
  Gastroenterology Insights.2024; 15(3): 661.     CrossRef
• Myrrh Essential Oil Improves DSS-Induced Colitis by Modulating the MAPK Signaling Pathway: In vitro and in vivo Studies
  Tiantian Tang, Yujiao Wang, Taotao Li, Ding Liu, Kai Yang, Jing Sun, Yajun Shi, Dongyan Guo, Junbo Zou, Fengyun Bai, Ying Sun, Mei Wang, Xiaofei Zhang
  Journal of Inflammation Research.2024; Volume 17: 5139.     CrossRef
• Engineering a Novel Probiotic Toolkit in Escherichia coli Nissle 1917 for Sensing and Mitigating Gut Inflammatory Diseases
  Nathalie Weibel, Martina Curcio, Atilla Schreiber, Gabriel Arriaga, Marine Mausy, Jana Mehdy, Lea Brüllmann, Andreas Meyer, Len Roth, Tamara Flury, Valerie Pecina, Kim Starlinger, Jan Dernič, Kenny Jungfer, Fabian Ackle, Jennifer Earp, Martin Hausmann, Ma
  ACS Synthetic Biology.2024; 13(8): 2376.     CrossRef
• Electroacupuncture at Zusanli regulates the pathological phenotype of inflammatory bowel disease by modulating the NLRP3 inflammasome pathway
  Yanqiang Chen, Miaomiao Cai, Boyuan Shen, Changchang Fan, Xiang Zhou
  Immunity, Inflammation and Disease.2024;[Epub]     CrossRef
• DJ-X-013 reduces LPS-induced inflammation, modulates Th17/ myeloid-derived suppressor cells, and alters NF-κB expression to ameliorate experimental colitis
  Mousumi Mandal, Ahmed Rakib, Md Abdullah Al Mamun, Santosh Kumar, Frank Park, Dong-Jin Hwang, Wei Li, Duane D. Miller, Udai P. Singh
  Biomedicine & Pharmacotherapy.2024; 179: 117379.     CrossRef
• Inflammatory Bowel Disease in Children
  Nabila Annisa Harum, Primadita Syahbani, Idznika Nurannisa Wibowo
  Archives of Pediatric Gastroenterology, Hepatology, and Nutrition.2024; 3(3): 38.     CrossRef
• Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection
  Walter Jauregui, Yozahandy A Abarca, Yasmin Ahmadi, Vaishnavi B Menon, Daniela A Zumárraga, Maria Camila Rojas Gomez , Aleeza Basri, Rohitha S Madala, Peter Girgis, Zahra Nazir
  Cureus.2024;[Epub]     CrossRef
• Recent Insight into Herbal Bioactives-based Novel Approaches for Chronic Intestinal Inflammatory Disorders Therapy
  Ranjit K. Harwansh, Sonia Chauhan, Rohitas Deshmukh, Rupa Mazumder
  Current Pharmaceutical Biotechnology.2024; 25(14): 1835.     CrossRef
• Air pollution exposure and inflammatory bowel disease: a systematic literature review of epidemiological and mechanistic studies
  Henrik Olstrup, Hani A. S. Mohamed, Julie Honoré, Jörg Schullehner, Torben Sigsgaard, Bertil Forsberg, Anna Oudin
  Frontiers in Environmental Health.2024;[Epub]     CrossRef
• Zhumeria majdae essential oil attenuates TNBS-induced colitis in rats by regulating inflammatory and apoptotic pathways
  Helia Aghamiri, Afrooz Mohammadgholi-Beiki, Rojin Rashidian, Manijeh Motevalian, Parvaneh Rahimi-Moghaddam, Mohammad Sheibani, Majid Jafari-Sabet
  Inflammopharmacology.2024;[Epub]     CrossRef
• Macadamia oil alleviates dextran sulfate sodium-induced ulcerative colitis in mice via activating the Nrf2/Ho-1 pathway
  Chunlan Shan, Ting Liu, Fujun Miao, Gangjun Guo
  Food Science and Biotechnology.2024;[Epub]     CrossRef
• A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn’s Disease
  Matthieu Allez, Bruce E Sands, Brian G Feagan, Geert D’Haens, Gert De Hertogh, Charles W Randall, Bin Zou, Jewel Johanns, Christopher O’Brien, Mark Curran, Rory Rebuck, Mei-Lun Wang, Nina Sabins, Thomas Baker, Taku Kobayashi
  Journal of Crohn's and Colitis.2023; 17(8): 1235.     CrossRef
• Angelica oil restores the intestinal barrier function by suppressing S100A8/A9 signalling in mice with ulcerative colitis
  Chang Liu, Yue-Xian He, Jia-Ning Zhang, Fang Yang, Shu-Yuan Wang, Ji-Liang Hu, Yang Yu
  Phytomedicine.2023; 108: 154490.     CrossRef
• Identification of anti-inflammatory components in Panax ginseng of Sijunzi Decoction based on spectrum-effect relationship
  Hong Kan, Dongxue Zhang, Weijia Chen, Shihan Wang, Zhongmei He, Shifeng Pang, Shuai Qu, Yingping Wang
  Chinese Herbal Medicines.2023; 15(1): 123.     CrossRef
• Starch from Pueraria lobata and the amylose fraction alleviates dextran sodium sulfate induced colitis in mice
  Yifei Yang, Mingxing Li, Qingsong Liu, Qianyun Zhao, Jiuping Zeng, Qin Wang, Yueshui Zhao, Fukuan Du, Yu Chen, Jing Shen, Haoming Luo, Shengpeng Wang, Wanping Li, Meijuan Chen, Xiaobing Li, Fang Wang, Yuhong Sun, Li Gu, Zhangang Xiao, Yu Du, Xu Wu
  Carbohydrate Polymers.2023; 302: 120329.     CrossRef
• Basiliximab therapy for immune‐mediated bowel disease in a pediatric heart transplant patient
  Amy L. Kiskaddon, Michael Wilsey, Ignacio Gonzalez‐Gomez, Jessica Laks, Alyssa Miles, Jennifer Carapellucci, Alfred Asante‐Korang
  Pediatric Transplantation.2023;[Epub]     CrossRef
• Controlling optical properties of small SWCNT using new N-doping chains method: A first-principles study
  R. Takassa, F. Elfatouaki, O. Farkad, S. Hassine, O. Choukri, A.E. Mouncharih, Y. Ijdiyaou, E.A. Ibnouelghazi, D. Abouelaoualim
  Physica E: Low-dimensional Systems and Nanostructures.2023; 148: 115627.     CrossRef
• Role of perioperative nutritional status and enteral nutrition in predicting and preventing post-operative complications in patients with Crohn’s disease
  Tianyu Jiang, Yongmei Jiang, Qianwen Jin, Shining Xu, Abraham Fingerhut, Yongmei Shi, Minhua Zheng, Zirui He
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• The Gut–Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases
  Natalia Di Tommaso, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani
  International Journal of Molecular Sciences.2023; 24(2): 1470.     CrossRef
• Salvia miltiorrhiza polysaccharide and its related metabolite 5-methoxyindole-3-carboxaldehyde ameliorate experimental colitis by regulating Nrf2/Keap1 signaling pathway
  Yu-Ping Fu, Xi Peng, Chao-Wen Zhang, Quan-Xing Jiang, Cen-Yu Li, Berit Smestad Paulsen, Frode Rise, Chao Huang, Bin Feng, Li-Xia Li, Xing-Fu Chen, Ren-Yong Jia, Yang-Ping Li, Xing-Hong Zhao, Gang Ye, Hua-Qiao Tang, Xiao-Xia Liang, Cheng Lv, Meng-Liang Tia
  Carbohydrate Polymers.2023; 306: 120626.     CrossRef
• Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy
  Mohamed J. Saadh, Maria V. Mikhailova, Soheil Rasoolzadegan, Mojgan Falaki, Roozbeh Akhavanfar, José Luis Arias Gonzáles, Amir Rigi, Bahman Abedi Kiasari
  European Journal of Medical Research.2023;[Epub]     CrossRef
• Revisiting the “starved gut” hypothesis in inflammatory bowel disease
  Sean P. Colgan, Ruth X. Wang, Caroline H.T. Hall, Geetha Bhagavatula, J. Scott Lee
  Immunometabolism.2023; 5(1): e0016.     CrossRef
• Hydroxytyrosol and Its Potential Uses on Intestinal and Gastrointestinal Disease
  Alessia Arangia, Ylenia Marino, Daniela Impellizzeri, Ramona D’Amico, Salvatore Cuzzocrea, Rosanna Di Paola
  International Journal of Molecular Sciences.2023; 24(4): 3111.     CrossRef
• Inhibition of NLRP3 attenuates sodium dextran sulfate-induced inflammatory bowel disease through gut microbiota regulation
  Shi-Le Wang, Man-Man Zhang, Han Zhou, Guo-Qiang Su, Yi Ding, Guang-Hui Xu, Xu Wang, Cheng-Fu Li, Wei-Feng Huang, Li-Tao Yi
  Biomedical Journal.2023; 46(5): 100580.     CrossRef
• Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
  Brent Brown, Vanshika Ojha, Ingo Fricke, Suhaila A Al-Sheboul, Chinua Imarogbe, Tanya Gravier, Michael Green, Lori Peterson, Ivoyl P. Koutsaroff, Ayça Demir, Jonatane Andrieu, Chiuan Yee Leow, Chiuan Herng Leow
  Vaccines.2023; 11(2): 408.     CrossRef
• Nsun2 coupling with RoRγt shapes the fate of Th17 cells and promotes colitis
  Wen-Lan Yang, Weinan Qiu, Ting Zhang, Kai Xu, Zi-Juan Gu, Yu Zhou, Heng-Ji Xu, Zhong-Zhou Yang, Bin Shen, Yong-Liang Zhao, Qi Zhou, Ying Yang, Wei Li, Peng-Yuan Yang, Yun-Gui Yang
  Nature Communications.2023;[Epub]     CrossRef
• Protective Effect of Lactiplantibacillus plantarum subsp. plantarum SC-5 on Dextran Sulfate Sodium—Induced Colitis in Mice
  Ruoran Shi, Fazheng Yu, Xueyu Hu, Yan Liu, Yuanyuan Jin, Honglin Ren, Shiying Lu, Jian Guo, Jiang Chang, Yansong Li, Zengshan Liu, Xiaoxu Wang, Pan Hu
  Foods.2023; 12(4): 897.     CrossRef
• Nitric Oxide, Neutrophil/Lymphocyte, and Platelet/Lymphocyte Ratios as Promising Inflammatory Biomarkers in Complicated Crohn’s Disease: Outcomes of Corticosteroids and Anti-TNF-α Therapies
  Imene Soufli, Abdelkrim Hablal, Samia Bessaad, Manel Amri, Moussa Labsi, Rania Sihem Boussa, Fahima Ameur, Houda Belguendouz, Sonia Ait Younes, Nassim Sid Idris, Chafia Touil-Boukoffa
  Inflammation.2023; 46(3): 1091.     CrossRef
• Inulin: properties and health benefits
  Yu-Qing Qin, Liu-Yan Wang, Xin-Yu Yang, Yi-Jie Xu, Gang Fan, Yan-Ge Fan, Jing-Nan Ren, Qi An, Xiao Li
  Food & Function.2023; 14(7): 2948.     CrossRef
• In Vitro Evaluation of the Most Active Probiotic Strains Able to Improve the Intestinal Barrier Functions and to Prevent Inflammatory Diseases of the Gastrointestinal System
  Alessandra Fusco, Vittoria Savio, Donatella Cimini, Sergio D’Ambrosio, Adriana Chiaromonte, Chiara Schiraldi, Giovanna Donnarumma
  Biomedicines.2023; 11(3): 865.     CrossRef
• RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis
  Kazutaka Takahashi, Kunitoshi Shigeyasu, Yoshitaka Kondo, Kazuyoshi Gotoh, Shuya Yano, Yuzo Umeda, Toshihiro Inokuchi, Caiming Xu, Kazuhiro Yoshida, Hibiki Umeda, Toshiaki Takahashi, Sho Takeda, Ryuichi Yoshida, Fuminori Teraishi, Hiroyuki Kishimoto, Yosh
  Journal of Crohn's and Colitis.2023; 17(5): 754.     CrossRef
• Donkey whey proteins ameliorate dextran sulfate sodium-induced ulcerative colitis in mice by downregulating the S100A8-TRAF6-NF-κB axis-mediated inflammatory response
  Mohan Li, Qilong Li, Rayhnigul Abdlla, Jiali Chen, Xiqing Yue, Siew Young Quek
  Food Science and Human Wellness.2023; 12(5): 1809.     CrossRef
• The oral microbiome in autoimmune diseases: friend or foe?
  Xiaoyan Huang, Xiangyu Huang, Yi Huang, Jiarong Zheng, Ye Lu, Zizhao Mai, Xinyuan Zhao, Li Cui, Shaohong Huang
  Journal of Translational Medicine.2023;[Epub]     CrossRef
• The Role of Seaweed Polysaccharides in Gastrointestinal Health: Protective Effect against Inflammatory Bowel Disease
  N. M. Liyanage, D. P. Nagahawatta, Thilina U. Jayawardena, You-Jin Jeon
  Life.2023; 13(4): 1026.     CrossRef
• ABX464 (Obefazimod) Upregulates miR-124 to Reduce Proinflammatory Markers in Inflammatory Bowel Diseases
  Cécile Apolit, Noëlie Campos, Audrey Vautrin, Christina Begon-Pescia, Laure Lapasset, Didier Scherrer, Paul Gineste, Hartmut Ehrlich, Aude Garcel, Julien Santo, Jamal Tazi
  Clinical and Translational Gastroenterology.2023; 14(4): e00560.     CrossRef
• Dietary protocatechuic acid redistributes tight junction proteins by targeting Rho-associated protein kinase to improve intestinal barrier function
  Bo Ram So, San Kim, Se Hyeon Jang, Min Jeong Kim, Jeong Jae Lee, Soo Rin Kim, Sung Keun Jung
  Food & Function.2023; 14(10): 4777.     CrossRef
• Experimental Murine Models for Colorectal Cancer Research
  Íris Neto, João Rocha, Maria Manuela Gaspar, Catarina P. Reis
  Cancers.2023; 15(9): 2570.     CrossRef
• Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China
  Kaituo Huang, Jing Liu, Wenhao Xia, Chuwen Tian, Lingya Yao, Qian Cao, Haotian Chen
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Reviewing not Homer’s Iliad, but “Kai Bao Ben Cao”: indigo dye—the past, present, and future
  Yusuke Yoshimatsu, Tomohisa Sujino, Takanori Kanai
  Intestinal Research.2023; 21(2): 174.     CrossRef
• Progress on Regulation of NLRP3 Inflammasome by Chinese Medicine in Treatment of Ulcerative Colitis
  Hao-xian Sun, Ying Zhu
  Chinese Journal of Integrative Medicine.2023; 29(8): 750.     CrossRef
• Identification of the informational and supportive needs of patients diagnosed with inflammatory bowel disease: a scoping review
  Narges Norouzkhani, Mahbobeh Faramarzi, Sara Ghodousi Moghadam, Mohammad Amin Karimi, Javad Shokri Shirvani, Ali Bahari, Mahdie ShojaeiBaghini, Saeid Eslami, Hamed Tabesh
  Frontiers in Psychology.2023;[Epub]     CrossRef
• New-Onset Crohn’s Disease following Initiation of Secukinumab: A Case Report and Review of the Role of IL-17 in the Pathogenesis of Crohn’s Disease
  Anas Khouri, Cesar Moreno, Benjamin Niland, Hirotada Akiho
  Case Reports in Gastrointestinal Medicine.2023; 2023: 1.     CrossRef
• A Holistic Perspective on How Photobiomodulation May Influence Fatigue, Pain, and Depression in Inflammatory Bowel Disease: Beyond Molecular Mechanisms
  E-Liisa Laakso, Tatjana Ewais
  Biomedicines.2023; 11(5): 1497.     CrossRef
• The Crosstalk between Gut Microbiota and Nervous System: A Bidirectional Interaction between Microorganisms and Metabolome
  Monica Montagnani, Lucrezia Bottalico, Maria Assunta Potenza, Ioannis Alexandros Charitos, Skender Topi, Marica Colella, Luigi Santacroce
  International Journal of Molecular Sciences.2023; 24(12): 10322.     CrossRef
• Fecal microbiota transplantation improves chicken growth performance by balancing jejunal Th17/Treg cells
  Ziyu Ma, Muhammad Akhtar, Hong Pan, Qiyao Liu, Yan Chen, Xinxin Zhou, Yingting You, Deshi Shi, Huazhen Liu
  Microbiome.2023;[Epub]     CrossRef
• Methylation-Regulated Long Non-Coding RNA Expression in Ulcerative Colitis
  Christopher G. Fenton, Mithlesh Kumar Ray, Wei Meng, Ruth H. Paulssen
  International Journal of Molecular Sciences.2023; 24(13): 10500.     CrossRef
• Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
  So Yoon Choi, Yiyoung Kwon, Sujin Choi, So Mi Lee, Byung-Ho Choe, Ben Kang
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Role of Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) in Immune and Inflammatory Diseases
  Xixi Bian, Honglu Xue, Dehuai Jing, Yan Wang, Guangxi Zhou, Fengqin Zhu
  Inflammation.2023; 46(5): 1612.     CrossRef
• Investigating association between inflammatory bowel disease and rotavirus vaccination in a paediatric cohort in the UK
  Aidan Flatt, Thomas Inns, Kate M. Fleming, Miren Iturriza-Gómara, Daniel Hungerford
  Epidemiology and Infection.2023;[Epub]     CrossRef
• Diet high in linoleic acid dysregulates the intestinal endocannabinoid system and increases susceptibility to colitis in Mice
  Poonamjot Deol, Paul Ruegger, Geoffrey D. Logan, Ali Shawki, Jiang Li, Jonathan D. Mitchell, Jacqueline Yu, Varadh Piamthai, Sarah H. Radi, Sana Hasnain, Kamil Borkowski, John W. Newman, Declan F. McCole, Meera G. Nair, Ansel Hsiao, James Borneman, France
  Gut Microbes.2023;[Epub]     CrossRef
• Ameliorative effect of aqueous extract of Carica papaya Linn. leaves on Acetic acid induced Ulcerative Colitis in Male Albino Wistar rats
  Rachana Govind Hublikar, Sadhana N Holla, Cheshmitha Minnamreddigari
  Research Journal of Pharmacy and Technology.2023; : 2147.     CrossRef
• Protopine Alleviates Dextran Sodium Sulfate-Induced Ulcerative Colitis by Improving Intestinal Barrier Function and Regulating Intestinal Microbiota
  Meishan Yue, Jialu Huang, Xiaolan Ma, Peng Huang, Yisong Liu, Jianguo Zeng
  Molecules.2023; 28(13): 5277.     CrossRef
• Chlorella vulgaris Modulates Gut Microbiota and Induces Regulatory T Cells to Alleviate Colitis in Mice
  Priyanka Velankanni, Seok-Ho Go, Jong Beom Jin, Jin-Soo Park, Sunhee Park, Su-Bin Lee, Ho-Keun Kwon, Cheol-Ho Pan, Kwang Hyun Cha, Choong-Gu Lee
  Nutrients.2023; 15(15): 3293.     CrossRef
• Discovery of a novel small molecule with efficacy in protecting against inflammation in vitro and in vivo by enhancing macrophages activation
  Cui Zhang, Zheng Cao, Hehua Lei, Chuan Chen, Ruichen Du, Yuchen Song, Ce Zhang, Jinlin Zhou, Yujing Lu, Luodong Huang, Peihong Shen, Limin Zhang
  Biomedicine & Pharmacotherapy.2023; 165: 115273.     CrossRef
• Anti-inflammatory potential of lactic acid bacteria from southern Brazil by reducing TNF-α and increasing IL-10 synthesis: an in vitro study
  Angélica Vincenzi, Márcia Inês Goettert, Claucia Fernanda Volken de Souza
  Journal of Applied Microbiology.2023;[Epub]     CrossRef
• A mannitol-modified emodin nano-drug restores the intestinal barrier function and alleviates inflammation in a mouse model of DSS-induced ulcerative colitis
  Yin-Yue Xu, Min Zhu, Jiang Wu, Long-Biao Luo, Si-jing Dong, Meng-Gai Zhang, Xue Liu, Ke Wang, Hua Luo, Wang-Hui Jing, Lin Wang, Si-Cen Wang
  Chinese Medicine.2023;[Epub]     CrossRef
• Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells
  Gregory Ian Robinson, Dongping Li, Bo Wang, Yeva Zahoruiko, Marta Gerasymchuk, Darryl Hudson, Olga Kovalchuk, Igor Kovalchuk
  Current Issues in Molecular Biology.2023; 45(8): 6743.     CrossRef
• Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn’s Disease, Intestinal Tuberculosis, and Behcet’s Disease
  Ji Won Yoo, Su In Jo, Dong Woo Shin, Ji Won Park, Sung-Eun Kim, Hyun Lim, Ho Suk Kang, Sung-Hoon Moon, Min Kyu Kim, Sang-Yeob Kim, Sung Wook Hwang, Jae Seung Soh
  Diagnostics.2023; 13(18): 2904.     CrossRef
• Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn’s disease
  Nathalie Van den Berghe, Dahham Alsoud, Bram Verstockt, Séverine Vermeire, Paul Declerck, Debby Thomas
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis
  Viviana Scalavino, Emanuele Piccinno, Anna Maria Valentini, Nicolò Schena, Raffaele Armentano, Gianluigi Giannelli, Grazia Serino
  Cells.2023; 12(17): 2184.     CrossRef
• The P2X7 Receptor in Autoimmunity
  Fabio Grassi, Gaia Salina
  International Journal of Molecular Sciences.2023; 24(18): 14116.     CrossRef
• Vaccination therapy for inflammatory bowel disease
  Yafei Liu, Fei Liao
  Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
• The Effect of Serotonin Transmission on Depressive and Insomnia Symptoms in Inflammatory Bowel Diseases
  Marcin Sochal, Alicja Witkowska, Agata Binienda, Agata Gabryelska, Piotr Białasiewicz, Jakub Fichna, Renata Talar-Wojnarowska, Ewa Małecka-Wojciesko
  Journal of Clinical Medicine.2023; 12(19): 6353.     CrossRef
• Cell membrane nanomaterials composed of phospholipids and glycoproteins for drug delivery in inflammatory bowel disease: A review
  Pengyu Lei, Haiyang Yu, Jiahui Ma, Jiao Du, Yimeng Fang, Qinsi Yang, Kun Zhang, Li Luo, Libo Jin, Wei Wu, Da Sun
  International Journal of Biological Macromolecules.2023; 249: 126000.     CrossRef
• Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis
  Ni Guo, Lu‐lu Lv
  Immunity, Inflammation and Disease.2023;[Epub]     CrossRef
• A new face of old cells: An overview about the role of senescence and telomeres in inflammatory bowel diseases
  Michał Sienkiewicz, Kamila Sroka, Agata Binienda, Diana Jurk, Jakub Fichna
  Ageing Research Reviews.2023; 91: 102083.     CrossRef
• The Earlier You Find, the Better You Treat: Red Flags for Early Diagnosis of Inflammatory Bowel Disease
  Laura Cantoro, Rita Monterubbianesi, Giuliano Falasco, Caterina Camastra, Paolo Pantanella, Mariangela Allocca, Rocco Cosintino, Roberto Faggiani, Silvio Danese, Gionata Fiorino
  Diagnostics.2023; 13(20): 3183.     CrossRef
• Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009–2020
  Joseph-Kevin Igwe, Phani Keerthi Surapaneni, Erin Cruz, Cedric Cole, Kingsley Njoku, Jisoo Kim, Ugo Alaribe, Kelechi Weze, Bilal Mohammed
  Obesity Surgery.2023; 33(11): 3472.     CrossRef
• Kynurenine pathway and its role in neurologic, psychiatric, and inflammatory bowel diseases
  Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, Zahra Ebrahim Soltani, Majid Jafari-Sabet, Mehdi Ghasemi, Ahmad Reza Dehpour
  Molecular Biology Reports.2023; 50(12): 10409.     CrossRef
• APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease
  Lauren Sahakian, Ainsley M. Robinson, Linda Sahakian, Rhian Stavely, Mark R. Kelley, Kulmira Nurgali
  Biomolecules.2023; 13(11): 1569.     CrossRef
• Imaging Agents for PET of Inflammatory Bowel Disease: A Review
  Farzaneh Rezazadeh, Aidan P. Kilcline, Nerissa T. Viola
  Journal of Nuclear Medicine.2023; 64(12): 1858.     CrossRef
• Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectives
  Chentao Zou, Xinquan Zan, Zhenyu Jia, Lu Zheng, Yijie Gu, Fei Liu, Ye Han, Chunfang Xu, Airong Wu, Qiaoming Zhi
  Clinical and Translational Medicine.2023;[Epub]     CrossRef
• Reclassification of Inflammatory Bowel Disease Type Unclassified by Small Bowel Capsule Endoscopy
  Ana-Maria Singeap, Catalin Sfarti, Irina Girleanu, Laura Huiban, Cristina Muzica, Sergiu Timofeiov, Carol Stanciu, Anca Trifan
  Medicina.2023; 59(12): 2064.     CrossRef
• Cytokine induced inflammatory bowel disease model using organ-on-a-chip technology
  Christine Tataru, Maya Livni, Carrie Marean-Reardon, Maria Clara Franco, Maude David, Masanori A. Murayama
  PLOS ONE.2023; 18(12): e0289314.     CrossRef
• Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue
  Gregory Ian Robinson, Dongping Li, Bo Wang, Tahiat Rahman, Marta Gerasymchuk, Darryl Hudson, Olga Kovalchuk, Igor Kovalchuk
  Life.2023; 13(12): 2345.     CrossRef
• Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion
  Philippe Pinton
  Annals of Medicine.2023;[Epub]     CrossRef
• Next -generation probiotics as potential therapeutic supplement for gastrointestinal infections
  Nidhi Gupta, Kajal Kachhawaha, Deepak Kumar Behera, Vijay Kumar Verma
  Pharmacological Research - Reports.2023; 1: 100002.     CrossRef
• Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis
  Kana Shiraishi, Shinya Furukawa, Sen Yagi, Kenichirou Mori, Tomoyuki Ninomiya, Keitarou Kawasaki, Yuji Mizukami, Seiyuu Suzuki, Masayoshi Uraoka, Naozumi Shibata, Sanae Nakamura, Satoshi Imamine, Hidehiro Murakami, Katsuhisa Ohashi, Masamoto Torisu, Makot
  Digestive Diseases and Sciences.2022; 67(1): 233.     CrossRef
• Epigenetic regulation of pediatric and neonatal immune responses
  Jennifer Bermick, Matthew Schaller
  Pediatric Research.2022; 91(2): 297.     CrossRef
• Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
  Hee Seung Hong, Jiwon Jung, Sang Hyoung Park, Hwa Jung Kim, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
  The Korean Journal of Internal Medicine.2022; 37(1): 73.     CrossRef
• Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review
  Maitreyi Raman, Vidya Rajagopalan, Sandeep Kaur, Raylene A Reimer, Christopher Ma, Subrata Ghosh, Jeff Vallance
  Inflammatory Bowel Diseases.2022; 28(7): 1100.     CrossRef
• Association between IL-10 rs3024505 and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis
  Meiling Liu, Wang Yuan, Sunmin Park
  Cytokine.2022; 149: 155721.     CrossRef
• Specificity of clinical decision support tools for vedolizumab and ustekinumab in biologically naïve patients with Crohn’s disease
  Ji Eun Kim, Hojeong Won, Young-Ho Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang
  Scandinavian Journal of Gastroenterology.2022; 57(4): 446.     CrossRef
• (RS)-bambuterol and its enantiomers: Potential improvement of (R)-bambuterol in mice with colitis
  Liangjun Deng, Shanping Wang, Haihua Guo, Xiaoming Liu, Xinfeng Zou, Rui Zhang, Yue Lin, Wen Tan
  International Immunopharmacology.2022; 103: 108501.     CrossRef
• Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
  Colin F. Craig, Rhiannon T. Filippone, Rhian Stavely, Joel C. Bornstein, Vasso Apostolopoulos, Kulmira Nurgali
  Journal of Neuroinflammation.2022;[Epub]     CrossRef
• Facilitation of colonic T cell immune responses is associated with an exacerbation of dextran sodium sulfate–induced colitis in mice lacking microsomal prostaglandin E synthase-1
  Fumiaki Kojima, Hiroki Sekiya, Yuka Hioki, Hitoshi Kashiwagi, Makoto Kubo, Masaki Nakamura, Shotaro Maehana, Yoshitaka Imamichi, Koh-ichi Yuhki, Fumitaka Ushikubi, Hidero Kitasato, Takafumi Ichikawa
  Inflammation and Regeneration.2022;[Epub]     CrossRef
• Protective Effect of Probiotics Isolated from Traditional Fermented Tea Leaves (Miang) from Northern Thailand and Role of Synbiotics in Ameliorating Experimental Ulcerative Colitis in Mice
  Napapan Kangwan, Sarawut Kongkarnka, Nitsara Boonkerd, Kridsada Unban, Kalidas Shetty, Chartchai Khanongnuch
  Nutrients.2022; 14(1): 227.     CrossRef
• Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis
  Silvio Danese, Barrett G. Levesque, Brian G. Feagan, Alina Jucov, Bal Raj Bhandari, Rish K. Pai, Kristen Taylor Meadows, Brian J. Kirby, Jean‐Marie Bruey, Allan Olson, Robin Osterhout, Courtney Van Biene, Julia Ford, Richard Aranda, Kartik Raghupathi, Wil
  Alimentary Pharmacology & Therapeutics.2022; 55(4): 401.     CrossRef
• The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis
  Aleksandra Kałużna, Paweł Olczyk, Katarzyna Komosińska-Vassev
  Journal of Clinical Medicine.2022; 11(2): 400.     CrossRef
• Anti‐ulcerative effects of wogonin on ulcerative colitis induced by dextran sulfate sodium via Nrf2/TLR4/NF‐κB signaling pathway in BALB/c mice
  Yadong Zhou, Fafu Dou, Huwei Song, Tao Liu
  Environmental Toxicology.2022; 37(4): 954.     CrossRef
• Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation
  Ainhoa Gonzalez-Pujana, Ana Beloqui, José Javier Aguirre, Manoli Igartua, Edorta Santos-Vizcaino, Rosa Maria Hernandez
  European Journal of Pharmaceutics and Biopharmaceutics.2022; 172: 31.     CrossRef
• Tea Tree Oil Terpinen-4-ol Protects Gut Barrier Integrity by Upregulation of Tight Junction Proteins via the ERK1/2-Signaling Pathway
  Yanhong Yong, Biao Fang, Yingxin Huang, Junyu Li, Tianyue Yu, Lianyun Wu, Canying Hu, Xiaoxi Liu, Zhichao Yu, Xingbin Ma, Ravi Gooneratne, Sidong Li, A. M. Abd El-Aty, Xianghong Ju
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease
  Bartolo Tamburini, Marco Pio La Manna, Lidia La Barbera, Leila Mohammadnezhad, Giusto Davide Badami, Mojtaba Shekarkar Azgomi, Francesco Dieli, Nadia Caccamo
  Cells.2022; 11(3): 455.     CrossRef
• Hyperactive neutrophil chemotaxis contributes to anti‐tumor necrosis factor‐α treatment resistance in inflammatory bowel disease
  Tung On Yau, Jayakumar Vadakekolathu, Gemma Ann Foulds, Guodong Du, Benjamin Dickins, Christos Polytarchou, Sergio Rutella
  Journal of Gastroenterology and Hepatology.2022; 37(3): 531.     CrossRef
• The role of diosgenin in crohn’s disease
  Sunday Ogundepo, Adinnu M. Chiamaka, Mercy Olatinwo, David Adepoju, Matthias Taiwo Aladesanmi, Ugwu Obiora Celestine, Kingsley Chijioke Ali, Ogochukwu Jennifer Umezinwa, Janet Olasore, Abdullahi Alausa
  Clinical Phytoscience.2022;[Epub]     CrossRef
• The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn’s Disease
  Omar Bushara, David Joseph Escobar, Samuel Edward Weinberg, Leyu Sun, Jie Liao, Guang-Yu Yang
  Pathobiology.2022; 89(4): 187.     CrossRef
• Splenic size as a marker for active inflammation in Crohn's disease
  Alla Khashper, Doron Shwartz, Benjamin Hyatt Taragin, Tamar Shalmon
  Clinical Imaging.2022; 84: 164.     CrossRef
• IBD-associated G protein-coupled receptor 65 variant compromises signalling and impairs key functions involved in inflammation
  Virginie Mercier, Gabrielle Boucher, Dominic Devost, Kyla Bourque, Azadeh Alikashani, Claudine Beauchamp, Alain Bitton, Sylvain Foisy, Philippe Goyette, Guy Charron, Terence E. Hébert, John D. Rioux
  Cellular Signalling.2022; 93: 110294.     CrossRef
• Cow Milk Extracellular Vesicle Effects on an In Vitro Model of Intestinal Inflammation
  Samanta Mecocci, Alessio Ottaviani, Elisabetta Razzuoli, Paola Fiorani, Daniele Pietrucci, Chiara Grazia De Ciucis, Silvia Dei Giudici, Giulia Franzoni, Giovanni Chillemi, Katia Cappelli
  Biomedicines.2022; 10(3): 570.     CrossRef
• Phycocyanin ameliorates mouse colitisviaphycocyanobilin-dependent antioxidant and anti-inflammatory protection of the intestinal epithelial barrier
  Wei Guo, Mingyong Zeng, Suqin Zhu, Shiyang Li, Yilin Qian, Haohao Wu
  Food & Function.2022; 13(6): 3294.     CrossRef
• Role of probiotics in the management of cervical cancer: An update
  Kusuma Kandati, Praveen Belagal, John Sushma Nannepaga, Buddolla Viswanath
  Clinical Nutrition ESPEN.2022; 48: 5.     CrossRef
• Protective Effect of Nelumbo nucifera Plant on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Rats
  Jignesh I. Patel, Monika Kumbhani, Morvi M. Raval
  Annals of the National Academy of Medical Sciences (India).2022; 58: 78.     CrossRef
• Serum Albumin to Globulin Ratio is Associated with the Presence and Severity of Inflammatory Bowel Disease
  Yanyan Wang, Chengyong Li, Weiyi Wang, Jiajia Wang, Jinhui Li, Shuangjie Qian, Chao Cai, Yuntao Liu
  Journal of Inflammation Research.2022; Volume 15: 1907.     CrossRef
• Pro-inflammatory effects of silver nanoparticles in the intestine
  Adelaide Sousa, Tracey D. Bradshaw, Daniela Ribeiro, Eduarda Fernandes, Marisa Freitas
  Archives of Toxicology.2022; 96(6): 1551.     CrossRef
• Aconitate Decarboxylase 1 Deficiency Exacerbates Mouse Colitis Induced by Dextran Sodium Sulfate
  Ho Won Kim, A-Reum Yu, Ji Won Lee, Hoe Sun Yoon, Byung Soo Lee, Hwan-Woo Park, Sung Ki Lee, Young Ik Lee, Jake Whang, Jong-Seok Kim
  International Journal of Molecular Sciences.2022; 23(8): 4392.     CrossRef
• Immune–related biomarkers shared by inflammatory bowel disease and liver cancer
  Thong Ba Nguyen, Duy Ngoc Do, Thuy T. P. Nguyen, Truc Ly Nguyen, Tung Nguyen-Thanh, Ha Thi Nguyen, Divijendra Natha Reddy Sirigiri
  PLOS ONE.2022; 17(4): e0267358.     CrossRef
• Naphthoquinone derivatives as P-glycoprotein inducers in inflammatory bowel disease: 2D monolayers, 3D spheroids, and in vivo models
  Nuha Mahmoud, Mohamed-Elamir F. Hegazy, Walaa Wadie, Mohamed Elbadawi, Edmond Fleischer, Anette Klinger, Gerhard Bringmann, Mohamed T. Khayyal, Thomas Efferth
  Pharmacological Research.2022; 179: 106233.     CrossRef
• Lactobacillus acidophilus and HKL Suspension Alleviates Ulcerative Colitis in Rats by Regulating Gut Microbiota, Suppressing TLR9, and Promoting Metabolism
  Kasimujiang Aximujiang, Kuerbannaimu Kaheman, Xilinguli Wushouer, Guixia Wu, Abulaiti Ahemaiti, Kurexi Yunusi
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Adipose tissue‐derived mesenchymal stem cells' acellular product extracellular vesicles as a potential therapy for Crohn's disease
  Jessica Altemus, Neda Dadgar, Yan Li, Amy L. Lightner
  Journal of Cellular Physiology.2022; 237(7): 3001.     CrossRef
• Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
  Hala Najeeb, Farah Yasmin, Salim Surani
  World Journal of Clinical Cases.2022; 10(14): 4327.     CrossRef
• Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma
  Dushyant Singh Dahiya, Abhilash Perisetti, Asim Kichloo, Amandeep Singh, Hemant Goyal, Laura Rotundo, Madhu Vennikandam, Hafeez Shaka, Gurdeep Singh, Jagmeet Singh, Sailaja Pisipati, Mohammad Al-Haddad, Madhusudhan R Sanaka, Sumant Inamdar
  World Journal of Gastrointestinal Pathophysiology.2022; 13(3): 85.     CrossRef
• Melatonin mediated inhibition of EZH2-NOS2 crosstalk attenuates inflammatory bowel disease in preclinical in vitro and in vivo models
  Mohammed Nadim Sardoiwala, Soni Jignesh Mohanbhai, Avinash Chandra Kushwaha, Atul Dev, Liku Biswal, Shyam Sunder Sharma, Subhasree Roy Choudhury, Surajit Karmakar
  Life Sciences.2022; 302: 120655.     CrossRef
• Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target
  Ruixuan You, Xinglan He, Zhuotong Zeng, Yi Zhan, Yangfan Xiao, Rong Xiao
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Inflammatory auto-immune diseases of the intestine and their management by natural bioactive compounds
  Naoual El Menyiy, Aicha El Allam, Sara Aboulaghras, Imane Jaouadi, Saad Bakrim, Nasreddine El Omari, Mohammad Ali Shariati, Alevtin Miftakhutdinov, Polrat Wilairatana, Mohammad S. Mubarak, Abdelhakim Bouyahya
  Biomedicine & Pharmacotherapy.2022; 151: 113158.     CrossRef
• Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases
  Niloufar Rahiman, Yuliya V. Markina, Prashant Kesharwani, Thomas P. Johnston, Amirhossein Sahebkar
  Journal of Controlled Release.2022; 348: 264.     CrossRef
• HucMSC-Ex carrying miR-203a-3p.2 ameliorates colitis through the suppression of caspase11/4-induced macrophage pyroptosis
  Yuting Xu, Xiaohua Tang, Anning Fang, Jialai Yan, Dickson Kofi Wiredu Ocansey, Xu Zhang, Fei Mao
  International Immunopharmacology.2022; 110: 108925.     CrossRef
• Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids
  Biki Gupta, Ravi Rai, Michael Oertel, Reben Raeman
  Seminars in Liver Disease.2022; 42(02): 122.     CrossRef
• 8-Oxypalmatine, a novel oxidative metabolite of palmatine, exhibits superior anti-colitis effect via regulating Nrf2 and NLRP3 inflammasome
  Juanjuan Cheng, Xingdong Ma, Haitao Zhang, Xiaoyan Wu, Minhua Li, Gaoxiang Ai, Ruoting Zhan, Jianhui Xie, Ziren Su, Xiaoqi Huang
  Biomedicine & Pharmacotherapy.2022; 153: 113335.     CrossRef
• Deciphering the interdependent labyrinth between gut microbiota and the immune system
  A. Saini, P. Dalal, D. Sharma
  Letters in Applied Microbiology.2022; 75(5): 1122.     CrossRef
• Null Function of Npr1 Disturbs Immune Response in Colonic Inflammation During Early Postnatal Stage
  Changkun Long, Hongfei Liu, Wenxing Zhan, Liping Chen, Andong Wu, Lin Yang, Shenghan Chen
  Inflammation.2022; 45(6): 2419.     CrossRef
• Antitumor necrosis factor treatment in patients with inflammatory bowel disease does not promote psoriasis development: A meta-analysis
  Yu Kyung Jun, Joo Young Park, Seong-Joon Koh, Hyunsun Park, Hyoun Woo Kang, Jong Pil Im, Joo Sung Kim
  Medicine.2022; 101(27): e29872.     CrossRef
• Association between intestinal microbiota and inflammatory bowel disease
  Yunchang Zhang, Xuemeng Si, Ling Yang, Hui Wang, Ye Sun, Ning Liu
  Animal Models and Experimental Medicine.2022; 5(4): 311.     CrossRef
• Intra-abdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn’s disease recurrence
  Salam P Bachour, Ravi S Shah, Florian Rieder, Taha Qazi, Jean Paul Achkar, Jessica Philpott, Bret Lashner, Stefan D Holubar, Amy L Lightner, Edward L Barnes, Jordan Axelrad, Miguel Regueiro, Benjamin Click, Benjamin L Cohen
  Journal of Crohn's and Colitis.2022; 16(11): 1696.     CrossRef
• The Business of T Cell Subsets and Cytokines in the Immunopathogenesis of Inflammatory Bowel Disease
  Shreekant Bharti, Mridushri Bharti
  Cureus.2022;[Epub]     CrossRef
• A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations
  Dushyant Singh Dahiya, Asim Kichloo, Farah Wani, Jagmeet Singh, Dhanshree Solanki, Hafeez Shaka
  Intestinal Research.2022; 20(3): 342.     CrossRef
• Hypoxia-Inducible Factor 1-Alpha Stabilizers in the Treatment of Inflammatory Bowel Diseases: Oxygen as a Novel IBD Therapy?
  Shubha Bhat, Florian Rieder
  Journal of Crohn's and Colitis.2022; 16(12): 1924.     CrossRef
• Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges
  Noemi Eiro, Maria Fraile, Alberto González-Jubete, Luis O. González, Francisco J. Vizoso
  International Journal of Molecular Sciences.2022; 23(16): 8905.     CrossRef
• Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review
  Chiara Puricelli, Elena Boggio, Casimiro Luca Gigliotti, Ian Stoppa, Salvatore Sutti, Roberta Rolla, Umberto Dianzani
  Pharmaceutics.2022; 14(9): 1782.     CrossRef
• Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics
  Thong Ba Nguyen, Duy Ngoc Do, My-Le Nguyen-Thi, Hiep Hoang-The, Thanh-Thoa Tran, Tung Nguyen-Thanh
  Computers in Biology and Medicine.2022; 149: 105996.     CrossRef
• Anxiolytic and anti-colitis effects of Moringa oleifera leaf-aqueous extract on acetic acid-induced colon inflammation in rat
  Paul Aimé Noubissi, Queendoline Njilifac, Michel Archange Fokam Tagne, Mireille Sylviane Dongmo Nguepi, Angèle Foyet Fondjo, Nadège Kouémou Emégam, Joseph Ngakou Mukam, Roger Zintchem, Henri Wambe, Gaétan Olivier Fankem, Agathe Fotio Tonfack, Jean Paul To
  Biomedicine & Pharmacotherapy.2022; 154: 113652.     CrossRef
• Identification of lncRNA DLEU2 as a potential diagnostic biomarker and anti-inflammatory target for ulcerative colitis
  Qiuling Lin, Dingguo Zhang, Jian Zhang, Weixiang Luo, Zhenglei Xu, Jun Yao, Lisheng Wang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Integrative bioinformatics analysis to identify the effects of circadian rhythm on Crohn’s disease
  Dan Liu, Yin-Yun Chen, Qing-qing Li, Ming Xu, Jiang-Tao Liao, Ben Wang
  Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
• Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis
  Arshdeep Singh, Ramit Mahajan, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Vandana Midha, Varun Mehta, Namita Bansal, Dharmatma Singh, Ajit Sood
  Indian Journal of Gastroenterology.2022; 41(4): 389.     CrossRef
• P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption
  Zhi-Feng Jiang, Wei Wu, Han-Bing Hu, Zheng-Yang Li, Ming Zhong, Lin Zhang
  World Journal of Gastroenterology.2022; 28(36): 5265.     CrossRef
• Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel Diseases
  Mohamad Karaky, Gabrielle Boucher, Saraï Mola, Sylvain Foisy, Claudine Beauchamp, Marie-Eve Rivard, Melanie Burnette, Hugues Gosselin, Alain Bitton, Guy Charron, Philippe Goyette, John D. Rioux, Tuuli Lappalainen
  PLOS Genetics.2022; 18(9): e1010189.     CrossRef
• Application of the Clustering Technique to Multiple Nutritional Factors Related to Inflammation and Disease Progression in Patients with Inflammatory Bowel Disease
  Agnieszka Dąbek-Drobny, Olga Kaczmarczyk, Agnieszka Piątek-Guziewicz, Michał Woźniakiewicz, Paweł Paśko, Justyna Dobrowolska-Iwanek, Aneta Woźniakiewicz, Aneta Targosz, Agata Ptak-Belowska, Paweł Zagrodzki, Małgorzata Zwolińska-Wcisło
  Nutrients.2022; 14(19): 3960.     CrossRef
• Ulcerative colitis complicated by autoimmune hepatitis-primary biliary cholangitis-primary sclerosing cholangitis overlap syndrome
  Miaoyu Jing, Wenjia Zhang, Min Xia
  Revista Española de Enfermedades Digestivas.2022;[Epub]     CrossRef
• Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa
  Laura D. Manzanares, Joseph David, Xingsheng Ren, Lenore K. Yalom, Enzo B. Piccolo, Yalda Dehghan, Aidan J. David, Stephen B. Hanauer, Ronen Sumagin
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Anti-TNFα Drugs and Interleukin Inhibitors: Epidemiological and Pharmacovigilance Investigation in COVID-19 Positive Patients
  Zaira Maraia, Tony Mazzoni, Marco Bruno Luigi Rocchi, Denise Feliciani, Maria Chiara Romani, Giovanna Acciarri, Stefania Rafaiani, Isidoro Mazzoni
  Journal of Personalized Medicine.2022; 12(11): 1770.     CrossRef
• Treatment with Extracellular Vesicles from Giardia lamblia Alleviates Dextran Sulfate Sodium-Induced Colitis in C57BL/6 Mice
  Hyun Jung Kim, Young-Ju Lee, Seon-Ok Back, Shin-Hyeong Cho, Hee-Il Lee, Myoung-Ro Lee
  The Korean Journal of Parasitology.2022; 60(5): 309.     CrossRef
• A novel gut inflammatory rat model by laparotomic injection of peptidoglycan from Staphylococcus aureus
  Savita Devi, Rajeev Kapila, Suman Kapila
  Archives of Microbiology.2022;[Epub]     CrossRef
• CROHN’S DISEASE: A REVIEW ON EPIDEMIOLOGY, DIAGNOSIS AND THERAPEUTIC MANAGEMENT
  Mohammad Mukim, Mohit Chaturvedi, Rakesh Patel, Supriya Roy, Pratishtha Sharma, Varunesh Chaturvedi, Saloni Goyal, Mohsina F. Patewkar
  Indian Drugs.2022; 59(09): 16.     CrossRef
• The emerging microbiome‐based approaches to IBD therapy: From SCFAs to urolithin A
  Mohammad Rudiansyah, Saade Abdalkareem Jasim, Bakhadir S. Azizov, Vadim Samusenkov, Walid Kamal Abdelbasset, Ghulam Yasin, Hawraa Jabbar Mohammad, Mohammed Abed Jawad, Trias Mahmudiono, Seyed Reza Hosseini‐Fard, Rasoul Mirzaei, Sajad Karampoor
  Journal of Digestive Diseases.2022; 23(8-9): 412.     CrossRef
• Mitochondrial Control in Inflammatory Gastrointestinal Diseases
  Guo-Yan Sui, Feng Wang, Jin Lee, Yoon Seok Roh
  International Journal of Molecular Sciences.2022; 23(23): 14890.     CrossRef
• Role of Vitamin D in Celiac Disease and Inflammatory Bowel Diseases
  Claudia Infantino, Roberta Francavilla, Adriana Vella, Sabrina Cenni, Nicola Principi, Caterina Strisciuglio, Susanna Esposito
  Nutrients.2022; 14(23): 5154.     CrossRef
• TDAG51 deficiency attenuates dextran sulfate sodium-induced colitis in mice
  Hyoeun Jeon, Dulshara Sachini Amarasekara, Nari Lee, Hye-Won Park, Jiyeon Yu, Jaerang Rho
  Scientific Reports.2022;[Epub]     CrossRef
• Old but Fancy: Curcumin in Ulcerative Colitis—Current Overview
  Aleksandra Pituch-Zdanowska, Łukasz Dembiński, Aleksandra Banaszkiewicz
  Nutrients.2022; 14(24): 5249.     CrossRef
• Dysregulated haemostasis in thrombo-inflammatory disease
  Paula A. Klavina, Gemma Leon, Annie M. Curtis, Roger J.S. Preston
  Clinical Science.2022; 136(24): 1809.     CrossRef
• p-Hydroxybenzoic Acid Ameliorates Colitis by Improving the Mucosal Barrier in a Gut Microbiota-Dependent Manner
  Xue Han, Miaomiao Li, Lijun Sun, Xinjuan Liu, Yue Yin, Jianyu Hao, Weizhen Zhang
  Nutrients.2022; 14(24): 5383.     CrossRef
• The study of tissue IgG4 in the mucous membrane of the colon in patients with inflammatory bowel disease
  Yu.M. Stepanov, T.S. Tarasova, M.V. Stoikevych, Yu.A. Gaydar, N.S. Fedorova
  GASTROENTEROLOGY.2022; 55(4): 246.     CrossRef
• Relationship between the humoral link of immunity, cytokine regulation with short-chain fatty acids in patients with inflammatory bowel diseases
  Yu.M. Stepanov, M.V. Stoikevych, I.A. Klenina, O.M. Tatarchuk
  GASTROENTEROLOGY.2022; 56(2): 103.     CrossRef
• Function of intestinal barrier protected by regulating the miR‐199a‐3p in ulcerative colitis: Modulation of IL‐23/IL‐17A axis
  Huixia Zhang, Fangbin Zhang, Wei Li
  Fundamental & Clinical Pharmacology.2021; 35(5): 852.     CrossRef
• Hyptis suaveolens (L.) Poit protects colon from TNBS-induced inflammation via immunomodulatory, antioxidant and anti-proliferative mechanisms
  Flávia Danniele Frota Machado, Rodrigo de Oliveira Formiga, Gedson Rodrigues de Morais Lima, Neyres Zínia Taveira de Jesus, Edvaldo Balbino Alves Júnior, Alexsandro Fernandes Marinho, Josean Fechine Tavares, Flávia Almeida Santos, Ana Flávia Seraine Custó
  Journal of Ethnopharmacology.2021; 265: 113153.     CrossRef
• Euterpe oleracea Mart. (Açaí) attenuates experimental colitis in rats: involvement of TLR4/COX-2/NF-ĸB
  Carlos Eduardo da Silva Monteiro, Humberto Barbosa da Costa Filho, Francisca Géssica Oliveira Silva, Maria de Fathima Felipe de Souza, Johnatan Alisson Oliveira Sousa, Álvaro Xavier Franco, Ângela Castro Resende, Roberto Soares de Moura, Marcellus Henriqu
  Inflammopharmacology.2021; 29(1): 193.     CrossRef
• Bile Acid Signaling in Inflammatory Bowel Diseases
  Stefano Fiorucci, Adriana Carino, Monia Baldoni, Luca Santucci, Emanuele Costanzi, Luigina Graziosi, Eleonora Distrutti, Michele Biagioli
  Digestive Diseases and Sciences.2021; 66(3): 674.     CrossRef
• Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD
  Elleni J Pippis, Bruce R Yacyshyn
  Inflammatory Bowel Diseases.2021; 27(10): 1674.     CrossRef
• Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed‐methods systematic review
  Suja P. Davis, Megan Suzanne Hardin Ross, Reuben Adatorwovor, Holly Wei
  Research in Nursing & Health.2021; 44(1): 155.     CrossRef
• The rationale for selenium supplementation in inflammatory bowel disease: A mechanism-based point of view
  Moein Ala, Zahedin Kheyri
  Nutrition.2021; 85: 111153.     CrossRef
• Enteric Viruses and Inflammatory Bowel Disease
  Georges Tarris, Alexis de Rougemont, Maëva Charkaoui, Christophe Michiels, Laurent Martin, Gaël Belliot
  Viruses.2021; 13(1): 104.     CrossRef
• Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
  Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
  Gut and Liver.2021; 15(1): 92.     CrossRef
• Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases
  Jayachandra Reddy Nakkala, Ziming Li, Wajiha Ahmad, Kai Wang, Changyou Gao
  Acta Biomaterialia.2021; 123: 1.     CrossRef
• Self‐Assembling Nanofibers Inhibit Inflammation in a Murine Model of Crohn's‐Disease‐Like Ileitis
  Matthew I. Bury, Natalie J. Fuller, Tristan D. Clemons, Renea M. Sturm, Christopher D. Morrison, Devon C. Lisy‐Snow, Bonnie G. Nolan, Christopher Tarczynski, Emily M. T. Ayello, Amber Boyce, Bridget Muckian, Nida Ahmad, Catherine J. Hunter, Mark R. Karver
  Advanced Therapeutics.2021;[Epub]     CrossRef
• Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib
  Maria Sole Chimenti, Paola Conigliaro, Livia Biancone, Roberto Perricone
  Therapeutic Advances in Musculoskeletal Disease.2021; 13: 1759720X2097777.     CrossRef
• The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights
  Zoya Qaiyum, Melissa Lim, Robert D. Inman
  Seminars in Immunopathology.2021; 43(2): 173.     CrossRef
• Extracellular Vesicles from Thapsigargin-Treated Mesenchymal Stem Cells Ameliorated Experimental Colitis via Enhanced Immunomodulatory Properties
  Hansol Joo, Mi-Kyung Oh, Ji Yeon Kang, Hyun Sung Park, Dong-Hoon Chae, Jieun Kim, Jong-Hee Lee, Hee Min Yoo, Uimook Choi, Do-Kyun Kim, Hakmo Lee, Sungjoo Kim, Kyung-Rok Yu
  Biomedicines.2021; 9(2): 209.     CrossRef
• Very early onset inflammatory bowel disease with compound heterozygous variants in Nuclear Factor of Activated T cell 5
  Nina V. Kirk, Jens M. B. Jensen, Mikkel S. Petersen, A. Al‐Mousawi, Trine H. Mogensen, Mette Christiansen, Carsten S. Larsen
  European Journal of Immunology.2021; 51(4): 999.     CrossRef
• Redox-active nanoparticles for inflammatory bowel disease
  Qinjuan Ren, Si Sun, Xiao-Dong Zhang
  Nano Research.2021; 14(8): 2535.     CrossRef
• Extracellular Vesicles and Immune System in Ageing and Immune Diseases
  So Yeong Cheon, Jong Eun Lee
  Experimental Neurobiology.2021; 30(1): 32.     CrossRef
• Role of vitamin D in Wnt pathway activation for colonic epithelial cell differentiation
  Satrio Wibowo, Krisni Subandiyah, Kusworini Handono, Sri Poeranto
  Journal of Taibah University Medical Sciences.2021; 16(4): 575.     CrossRef
• The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
  Dan-in Jang, A-Hyeon Lee, Hye-Yoon Shin, Hyo-Ryeong Song, Jong-Hwi Park, Tae-Bong Kang, Sang-Ryong Lee, Seung-Hoon Yang
  International Journal of Molecular Sciences.2021; 22(5): 2719.     CrossRef
• Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease
  Yijie Song, Yuge Zhao, Yueming Ma, Zhicheng Wang, Lan Rong, Bing Wang, Ning Zhang
  Cytokine & Growth Factor Reviews.2021; 60: 61.     CrossRef
• Innate Lymphoid Cells and Adaptive Immune Cells Cross-Talk: A Secret Talk Revealed in Immune Homeostasis and Different Inflammatory Conditions
  Vijay Kumar
  International Reviews of Immunology.2021; 40(3): 217.     CrossRef
• Mast Cell Mediated Regulation of Small Intestinal Chloride Malabsorption in SAMP1/YitFc Mouse Model of Spontaneous Chronic Ileitis
  M Motiur Rahman, Sheuli Afroz, Subha Arthur, Uma Sundaram
  Cells.2021; 10(3): 697.     CrossRef
• Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease
  Katsuyoshi Matsuoka, Makoto Naganuma, Toshifumi Hibi, Hirohito Tsubouchi, Kiyoshi Oketani, Toshinori Katsurabara, Seiichiro Hojo, Osamu Takenaka, Tetsu Kawano, Toshio Imai, Takanori Kanai
  Journal of Gastroenterology and Hepatology.2021; 36(8): 2180.     CrossRef
• Th17 immune response in inflammatory bowel disease: Future roles and opportunities for lactic acid bacteria and bioactive compounds released in fermented milk
  Lourdes Santiago-López, Adrián Hernández-Mendoza, Belinda Vallejo-Cordoba, Abraham Wall-Medrano, Aarón F. González-Córdova
  Trends in Food Science & Technology.2021; 112: 109.     CrossRef
• PDE9 Inhibitor PF-04447943 Attenuates DSS-Induced Colitis by Suppressing Oxidative Stress, Inflammation, and Regulating T-Cell Polarization
  Mohammad Nasiruddin Rana, Jie Lu, Enfu Xue, Jingjing Ruan, Yuting Liu, Lejun Zhang, Rana Dhar, Yajun Li, Zhengqiang Hu, Jie Zhou, Wangqian Ma, Huifang Tang
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• The effects of flaxseed supplementation on metabolic syndrome parameters, insulin resistance and inflammation in ulcerative colitis patients: An open‐labeled randomized controlled trial
  Nava Morshedzadeh, Mehran Rahimlou, Shabnam Shahrokh, Soheila Karimi, Parvin Mirmiran, Mohammad Reza Zali
  Phytotherapy Research.2021; 35(7): 3781.     CrossRef
• Edible Bird’s Nest Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in C57BL/6J Mice by Restoring the Th17/Treg Cell Balance
  Yaohua Fan, Yanqun Fan, Kunfeng Liu, Piyanuch Lonan, Feng Liao, Yuhang Huo, Xiaohua Zhong, Yueliang Liang, Yaxin Wang, Shaozhen Hou, Xiaoping Lai, Geng Li, Weihong Kuang
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Redox imbalance in Crohn's disease patients is modulated by Azathioprine
  Mohammad Javad Tavassolifar, Mostafa Changaei, Zahra Salehi, Fatemeh Ghasemi, Moslem Javidan, Mohammad Hossein Nicknam, Mohammad Reza Pourmand
  Redox Report.2021; 26(1): 80.     CrossRef
• Immune Protection of a Helminth Protein in the DSS-Induced Colitis Model in Mice
  Shao Rong Long, Ruo Dan Liu, Deepak Vijaya Kumar, Zhong Quan Wang, Chien-Wen Su
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Effect of Size and Loading of Retinoic Acid in Polyvinyl Butyrate Nanoparticles on Amelioration of Colitis
  Jinting Li, Yunmei Mu, Yiwei Liu, Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama
  Polymers.2021; 13(9): 1472.     CrossRef
• Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders
  Fabrizio Michetti, Gabriele Di Sante, Maria Elisabetta Clementi, Beatrice Sampaolese, Patrizia Casalbore, Cinzia Volonté, Vincenzo Romano Spica, Pier Paolo Parnigotto, Rosa Di Liddo, Susanna Amadio, Francesco Ria
  Neuroscience & Biobehavioral Reviews.2021; 127: 446.     CrossRef
• Intestinal production of secreted protein acidic and rich in cysteine (SPARC) in patients with ulcerative colitis
  Gabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Natalia Razo-López, Rafael Barreto-Zúñiga, Braulio Martínez-Benítez, Jesús K. Yamamoto-Furusho
  Immunobiology.2021; 226(3): 152095.     CrossRef
• Root Extract of Lindera aggregata (Sims) Kosterm. Modulates the Th17/Treg Balance to Attenuate DSS-Induced Colitis in Mice by IL-6/STAT3 Signaling Pathway
  Huimin Lai, Zhengbiao Yang, Zhaohuan Lou, Feng Li, Feng Xie, Wei Pan, Cong Xu, Lili Zhang, Sheng Zhang, Lijiang Zhang, Mincong Huang
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Bile Acids Activated Receptors in Inflammatory Bowel Disease
  Michele Biagioli, Silvia Marchianò, Adriana Carino, Cristina Di Giorgio, Luca Santucci, Eleonora Distrutti, Stefano Fiorucci
  Cells.2021; 10(6): 1281.     CrossRef
• Protective effects of potential probiotic Lactobacillus rhamnosus (MTCC-5897) fermented whey on reinforcement of intestinal epithelial barrier function in a colitis-induced murine model
  Harpreet Kaur, Taruna Gupta, Suman Kapila, Rajeev Kapila
  Food & Function.2021; 12(13): 6102.     CrossRef
• Characterization of terminal-ileal and colonic Crohn’s disease in treatment-naïve paediatric patients based on transcriptomic profile using logistic regression
  Ilkyu Park, Jaeeun Jung, Sugi Lee, Kunhyang Park, Jea-Woon Ryu, Mi-Young Son, Hyun-Soo Cho, Dae-Soo Kim
  Journal of Translational Medicine.2021;[Epub]     CrossRef
• Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
  Marcello Candelli, Laura Franza, Giulia Pignataro, Veronica Ojetti, Marcello Covino, Andrea Piccioni, Antonio Gasbarrini, Francesco Franceschi
  International Journal of Molecular Sciences.2021; 22(12): 6242.     CrossRef
• Fabrication and Evaluation of Celecoxib Oral Oleogel to Reduce the Inflammation of Ulcerative Colitis
  Nermin M. Sheta, Sylvia A. Boshra
  AAPS PharmSciTech.2021;[Epub]     CrossRef
• Glycine Attenuates Citrobacter rodentium‐Induced Colitis by Regulating ATF6‐Mediated Endoplasmic Reticulum Stress in Mice
  Yunchang Zhang, Da Jiang, Yuhang Jin, Hai Jia, Ying Yang, In Ho Kim, Zhaolai Dai, Jinhua Zhang, Fazheng Ren, Zhenlong Wu
  Molecular Nutrition & Food Research.2021;[Epub]     CrossRef
• Critical roles of microRNA-196 in normal physiology and non-malignant diseases: Diagnostic and therapeutic implications
  Milad Bastami, Andrea Masotti, Zahra Saadatian, Abdolreza Daraei, Mojtaba Farjam, Ali Ghanbariasad, Sepideh Zununi Vahed, Shirin Eyvazi, Yaser Mansoori, Ziba Nariman-Saleh-Fam
  Experimental and Molecular Pathology.2021; 122: 104664.     CrossRef
• Prevalence of, and factors associated with, long-term COVID-19 sick leave in working-age patients followed in general practices in Germany
  Louis Jacob, Ai Koyanagi, Lee Smith, Christian Tanislav, Marcel Konrad, Susanne van der Beck, Karel Kostev
  International Journal of Infectious Diseases.2021; 109: 203.     CrossRef
• Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target
  Ehsan Nourbakhsh, Ali Mohammadi, Mohammad Salemizadeh Parizi, Atena Mansouri, Farnoosh Ebrahimzadeh
  Inflammopharmacology.2021; 29(5): 1307.     CrossRef
• Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice
  Sushmita Negi, Sheetal Saini, Nikunj Tandel, Kiran Sahu, Ravi P.N. Mishra, Rajeev K. Tyagi
  Cells.2021; 10(8): 1847.     CrossRef
• Effect of resistance exercise training on Crohn’s disease patients
  Konstantinos Papadimitriou
  Intestinal Research.2021; 19(3): 275.     CrossRef
• Dysbiotic microbiota interactions in Crohn’s disease
  Esther Caparrós, Reiner Wiest, Michael Scharl, Gerhard Rogler, Ana Gutiérrez Casbas, Bahtiyar Yilmaz, Marcin Wawrzyniak, Rubén Francés
  Gut Microbes.2021;[Epub]     CrossRef
• Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis
  Junfeng Zou, Chen Liu, Shu Jiang, Dawei Qian, Jinao Duan, Anthony R. Richardson
  Infection and Immunity.2021;[Epub]     CrossRef
• The Role of T Follicular Helper Cells and Interleukin-21 in the Pathogenesis of Inflammatory Bowel Disease
  Lulu Sun, Ruixue Kong, Hua Li, Dashan Wang, Paul A. Rufo
  Gastroenterology Research and Practice.2021; 2021: 1.     CrossRef
• Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models
  Kanika Suri, Jason A. Bubier, Michael V. Wiles, Leonard D. Shultz, Mansoor M. Amiji, Vishnu Hosur
  Cells.2021; 10(9): 2204.     CrossRef
• Anti-inflammatory effects of DA-9601, an extract of Artemisia asiatica, on aceclofenac-induced acute enteritis
  Ju Hwan Kim, Chang Yell Shin, Sun Woo Jang, Dong-Seok Kim, Wonae Lee, Hyung-Gun Kim, Hak Rim Kim
  The Korean Journal of Physiology & Pharmacology.2021; 25(5): 439.     CrossRef
• Common contributing factors to COVID-19 and inflammatory bowel disease
  Ronald Neil Kostoff, Michael Brandon Briggs, Darja Kanduc, Darla Roye Shores, Leda Kovatsi, Alexander I. Vardavas, Alan L. Porter
  Toxicology Reports.2021; 8: 1616.     CrossRef
• Protective Effect of Salvianolic Acid B in Acetic Acid-Induced Experimental Colitis in a Mouse Model
  Mydhili Govindarasu, Mohammad Azam Ansari, Mohammad N. Alomary, Sami AlYahya, Saad Alghamdi, Azzah M. Bannunah, Mazen Almehmadi, Pari Abirami, Ekambaram Gayathiri, Mariyappan Palani, Govindasamy Rajakumar, Muthu Thiruvengadam, Manju Vaiyapuri
  Processes.2021; 9(9): 1589.     CrossRef
• Active Ingredients and Potential Mechanisms of the Gan Jiang-Huang Qin-Huang Lian-Ren Shen Decoction against Ulcerative Colitis: A Network Pharmacology and Molecular Docking-Based Study
  Ce Zhou, Hang Zhou, Furong Zhang, Liangliang Hao, Jing Guo, Duygu Ağagündüz
  Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
• Short-term tolerability and effectiveness of methotrexate monotherapy in adult patients with Crohn’s disease: a retrospective study
  Hee Seung Hong, Kyuwon Kim, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
  Therapeutic Advances in Gastroenterology.2021; 14: 175628482110430.     CrossRef
• Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review
  Kamila Majidova, Julia Handfield, Kamran Kafi, Ryan D. Martin, Ryszard Kubinski
  Genes.2021; 12(10): 1465.     CrossRef
• Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
  William J. Sandborn, Brian G. Feagan, Geert D’Haens, Douglas C. Wolf, Igor Jovanovic, Stephen B. Hanauer, Subrata Ghosh, AnnKatrin Petersen, Steven Y. Hua, Ji Hwan Lee, Lorna Charles, Denesh Chitkara, Keith Usiskin, Jean-Frederic Colombel, Loren Laine, Si
  New England Journal of Medicine.2021; 385(14): 1280.     CrossRef
• The combined supplementation of omega-3 fatty acids and probiotics decreased the levels of serum polyamines in experimental colitis
  Havvanur Yoldaş İlktaç, Nihal Büyükuslu, Cüneyd Parlayan
  Food and Health.2021; 7(4): 279.     CrossRef
• High-altitude hypoxia exacerbates dextran sulfate sodium (DSS)-induced colitis by upregulating Th1 and Th17 lymphocytes
  Mohammed Gamah, Murad Alahdal, Yu Zhang, Yiling Zhou, Qiaorong Ji, Zhouyang Yuan, Ying Han, Xiangqun Shen, Yanming Ren, Wei Zhang
  Bioengineered.2021; 12(1): 7985.     CrossRef
• The incidence of psoriasis among smokers and/or former smokers inflammatory bowel diseases patients treated with tumor necrosis factor antagonist
  Meiqi Yang, Weixin Liu, Qiuping Deng, Zeng Liang, Qin Wang
  Medicine.2021; 100(42): e27510.     CrossRef
• Host-Related Laboratory Parameters for Leprosy Reactions
  Yuqian Luo, Mitsuo Kiriya, Kazunari Tanigawa, Akira Kawashima, Yasuhiro Nakamura, Norihisa Ishii, Koichi Suzuki
  Frontiers in Medicine.2021;[Epub]     CrossRef
• The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer
  Patrycja Kłos, Siarhei A. Dabravolski
  International Journal of Molecular Sciences.2021; 22(21): 11673.     CrossRef
• Crohn’s disease at radiological imaging: focus on techniques and intestinal tract
  Giuseppe Cicero, Silvio Mazziotti
  Intestinal Research.2021; 19(4): 365.     CrossRef
• Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease
  Yongyan Chen, Wenwen Cui, Xiao Li, Huan Yang
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Association Between Peripheral Blood Monocyte Count and Mucosal Healing in Japanese Patients With Ulcerative Colitis
  Shinya Furukawa, Yoshio Ikeda, Sen Yagi, Teruki Miyake, Kana Shiraishi, Kazuhiro Tange, Yu Hashimoto, Kenichirou Mori, Tomoyuki Ninomiya, Seiyuu Suzuki, Naozumi Shibata, Hidehiro Murakami, Katsuhisa Ohashi, Aki Hasebe, Hideomi Tomida, Yasunori Yamamoto, E
  Clinical and Translational Gastroenterology.2021; 12(11): e00429.     CrossRef
• Microscopic colitis and the role of the specialist inflammatory bowel disease nurse: a clinical review
  Cathy Walsh
  Gastrointestinal Nursing.2021; 19(9): 20.     CrossRef
• Food Habit Associated Mycobiota Composition and Their Impact on Human Health
  Jata Shankar
  Frontiers in Nutrition.2021;[Epub]     CrossRef
• Immunogenicity profile in African green monkeys of a vaccine candidate based on a mutated form of human Interleukin-15
  Yunier Rodríguez-Álvarez, Lino Gerardo Batista-Roche, Alexey Llopiz-Arzuaga, Pedro Puente-Pérez, Rafael Martínez-Castillo, Jorge Castro-Velazco, Alicia Santos-Savio
  BMC Immunology.2021;[Epub]     CrossRef
• A Novel Role of Dapagliflozin in Mitigation of Acetic Acid-Induced Ulcerative Colitis by Modulation of Monocyte Chemoattractant Protein 1 (MCP-1)/Nuclear Factor-Kappa B (NF-κB)/Interleukin-18 (IL-18)
  Mohamed Kh. ElMahdy, Samar A. Antar, Ehab Kotb Elmahallawy, Walied Abdo, Hayfa Hussin Ali Hijazy, Ashraf Albrakati, Ahmed E. Khodir
  Biomedicines.2021; 10(1): 40.     CrossRef
• Anti-inflammatory effects of apocynin: a narrative review of the evidence
  Maryam Boshtam, Shirin Kouhpayeh, Farahnaz Amini, Yadollah Azizi, Malihe Najaflu, Laleh Shariati, Hossein Khanahmad
  All Life.2021; 14(1): 997.     CrossRef
• Autoimmune profile of rat blood in experimental ulcerative colitis
  E. V. Davydova, M. V. Osikov, A. E. Bakeeva, N. V. Kaigorodtseva
  Russian Journal of Immunology.2021; 24(2): 209.     CrossRef
• 1
  Yu.M. Stepanov, T.S. Tarasova, M.V. Stoykevich
  GASTROENTEROLOGY.2021; 55(1): 54.     CrossRef
• Crohn’s disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population‐based study
  Hosim Soh, Jong Pil Im, Kyungdo Han, Seona Park, Seung Wook Hong, Jeong Min Moon, Eun Ae Kang, Jaeyoung Chun, Hyun Jung Lee, Joo Sung Kim
  Alimentary Pharmacology & Therapeutics.2020; 51(4): 446.     CrossRef
• Upregulated IL‐17A secretion and CCR6 co‐expression in Treg subsets are related to the imbalance of Treg/Th17 cells in active UC patients
  Yan Long, Xiaotao Zhao, Changsheng Xia, Xiaoxu Li, Chunhong Fan, Chen Liu, Chengbin Wang
  Scandinavian Journal of Immunology.2020;[Epub]     CrossRef
• Intestinal Epithelial Deletion of Sphk1 Prevents Colitis-Associated Cancer Development by Inhibition of Epithelial STAT3 Activation
  Seung Bin Park, Byung-il Choi, Beom Jae Lee, Nam Joo Kim, Yoon A. Jeong, Moon Kyung Joo, Hyo Jung Kim, Jong-Jae Park, Jae Seon Kim, Yoon-Seok Noh, Hyun Joo Lee
  Digestive Diseases and Sciences.2020; 65(8): 2284.     CrossRef
• Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down‐regulating the nuclear factor‐kappa B signaling
  Tian Hua Ren, Min Min Lv, Xiao Meng An, Wai Keung Leung, Wai‐Kay Seto
  Journal of Digestive Diseases.2020; 21(1): 38.     CrossRef
• Phenylethyl isothiocyanate induces oxidative damage of porcine kidney cells mediated by reactive oxygen species
  Yuanyuan Zhu, Shuiping Liu, Sisi Yan, Ji Wang, Linyu Zhang, Xin LI, Lixin Wen, Jing Wu
  Journal of Biochemical and Molecular Toxicology.2020;[Epub]     CrossRef
• Recovery of CD226-TIGIT+FoxP3+ and CD226-TIGIT-FoxP3+ regulatory T cells contributes to clinical remission from active stage in ulcerative colitis patients
  Yan Long, Chengbin Wang, Changsheng Xia, Xiaoxu Li, Chunhong Fan, Xiaotao Zhao, Chen Liu
  Immunology Letters.2020; 218: 30.     CrossRef
• Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Yonsei Medical Journal.2020; 61(1): 48.     CrossRef
• Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels
  Mohammad Tauqeer Alam, Gregory C. A. Amos, Andrew R. J. Murphy, Simon Murch, Elizabeth M. H. Wellington, Ramesh P. Arasaradnam
  Gut Pathogens.2020;[Epub]     CrossRef
• RETRACTED: miRNA-129/FBW7/NF-κB, a Novel Regulatory Pathway in Inflammatory Bowel Disease
  Qinghui Meng, Weihua Wu, Tiemin Pei, Junlin Xue, Peng Xiao, Liang Sun, Long Li, Desen Liang
  Molecular Therapy - Nucleic Acids.2020; 19: 731.     CrossRef
• Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea
  Yoon Suk Jung
  Gut and Liver.2020; 14(1): 3.     CrossRef
• Presence of PTPN2 SNP rs1893217 Enhances the Anti-inflammatory Effect of Spermidine
  Anna Niechcial, Matthias Butter, Salomon Manz, Nicole Obialo, Katharina Bäbler, Lisa van der Lely, Silvia Lang, Claudia Gottier, Declan F McCole, Michael Scharl, Marianne R Spalinger
  Inflammatory Bowel Diseases.2020; 26(7): 1038.     CrossRef
• Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases
  Minjie Wan, Lili Ding, Dong Wang, Jiawen Han, Pujun Gao
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy
  Jihye Kim, Jong Pil Im, Jae-Joon Yim, Chang Kyun Lee, Dong Il Park, Chang Soo Eun, Sung-Ae Jung, Jeong Eun Shin, Kang-Moon Lee, Jae Hee Cheon
  The Korean Journal of Gastroenterology.2020; 75(1): 29.     CrossRef
• Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist
  Emily Weaver, Eva Szigethy
  Current Gastroenterology Reports.2020;[Epub]     CrossRef
• Co-expression of master transcription factors determines CD4+ T cell plasticity and functions in auto-inflammatory diseases
  Bhalchandra Mirlekar
  Immunology Letters.2020; 222: 58.     CrossRef
• Sestrin3 enhances macrophage-mediated generation of T helper 1 and T helper 17 cells in a mouse colitis model
  Liuqing Ge, Min Xu, Steven R Brant, Shaoping Liu, Chengliang Zhu, Jian Shang, Qiu Zhao, Feng Zhou
  International Immunology.2020; 32(6): 421.     CrossRef
• Aspects of free radical oxidation in the large bowel in ulcerative colitis and Crohn’s disease
  MV Osikov, EV Davydova, MS Boyko, AE Bakeeva, NV Kaygorodtseva, IR Galeeva, AA Fedosov, MA Ilyinyh, LV Vorgova
  Bulletin of Russian State Medical University.2020; ((3)2020): 58.     CrossRef
• Similar Clinical Outcomes of Early and Late Anti-TNF Initiation for Ulcerative Colitis: A Nationwide Population-Based Study
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Yonsei Medical Journal.2020; 61(5): 382.     CrossRef
• Elucidation of colon-protective efficacy of diosgenin in experimental TNBS-induced colitis: inhibition of NF-κB/IkB-α and Bax/Caspase-1 signaling pathways
  Xiaobo Tang, Gengzhen Huang, Tao Zhang, Shiqing Li
  Bioscience, Biotechnology, and Biochemistry.2020; 84(9): 1903.     CrossRef
• Lessons on the Sigma-1 Receptor in TNBS-Induced Rat Colitis: Modulation of the UCHL-1, IL-6 Pathway
  Nikoletta Almási, Szilvia Török, Szabolcs Dvorácskó, Csaba Tömböly, Ákos Csonka, Zoltán Baráth, Zsolt Murlasits, Zsuzsanna Valkusz, Anikó Pósa, Csaba Varga, Krisztina Kupai
  International Journal of Molecular Sciences.2020; 21(11): 4046.     CrossRef
• Extracts and Marine Algae Polysaccharides in Therapy and Prevention of Inflammatory Diseases of the Intestine
  Natalya N. Besednova, Tatyana S. Zaporozhets, Tatyana A. Kuznetsova, Ilona D. Makarenkova, Sergey P. Kryzhanovsky, Lydmila N. Fedyanina, Svetlana P. Ermakova
  Marine Drugs.2020; 18(6): 289.     CrossRef
• Making a big impact with small datasets using machine-learning approaches
  May Y Choi, Christopher Ma
  The Lancet Rheumatology.2020; 2(8): e451.     CrossRef
• Immunotropic effect of rectal suppositories with vitamin D3 in dynamics of experimental ulcer colitis
  M. V. Osikov, E. V. Simonyan, M. S. Boyko, A. M. Bogomolova
  Experimental and Clinical Gastroenterology.2020; (6): 141.     CrossRef
• Oleoylethanolamide Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats
  Shinsuke Otagiri, Shunsuke Ohnishi, Masatsugu Ohara, Qingjie Fu, Koji Yamamoto, Keiko Yamamoto, Takehiko Katsurada, Naoya Sakamoto
  Frontiers in Pharmacology.2020;[Epub]     CrossRef
• Role of mesenchymal stem cell derived extracellular vesicles in autoimmunity: A systematic review
  Jing-Hua Wang, Xiao-Ling Liu, Jian-Mei Sun, Jing-Han Yang, Dong-Hua Xu, Shu-Shan Yan
  World Journal of Stem Cells.2020; 12(8): 879.     CrossRef
• Impact of early anti-TNF use on clinical outcomes in Crohn’s disease: a nationwide population-based study
  Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2020; 35(5): 1104.     CrossRef
• Red light-emitting diode treatment improves tissue recovery in DSS-induced colitis in mice
  Marina de Paula-Silva, Milena Fronza Broering, Pablo Scharf, Gustavo Henrique Oliveira da Rocha, Sandra Farsky, Adriana Lino-dos-Santos-Franco
  Journal of Photochemistry and Photobiology B: Biology.2020; 212: 112018.     CrossRef
• Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model
  Jung Min Kim, Da Hye Kim, Hyo Jeong Park, Hyun Woo Ma, I Seul Park, Mijeong Son, So Youn Ro, Seokmann Hong, Hyo Kyung Han, Soo Jeong Lim, Seung Won Kim, Jae Hee Cheon
  Journal of Nanobiotechnology.2020;[Epub]     CrossRef
• Dietary Supplementation with Spray-Dried Porcine Plasma Attenuates Colon Inflammation in a Genetic Mouse Model of Inflammatory Bowel Disease
  Lluïsa Miró, Concepció Amat, Cristina Rosell-Cardona, Joy M. Campbell, Javier Polo, Anna Pérez-Bosque, Miquel Moretó
  International Journal of Molecular Sciences.2020; 21(18): 6760.     CrossRef
• Synergistic therapeutic effect of mesenchymal stem cells and tolerogenic dendritic cells in an acute colitis mouse model
  Hajar Abbasi-Kenarsari, Neda Heidari, Kaveh Baghaei, Davar Amani, Mohammad Reza Zali, Sahar Gaffari Khaligh, Abbas Shafiee, Seyed Mahmoud Hashemi
  International Immunopharmacology.2020; 88: 107006.     CrossRef
• SOD1 suppresses pro-inflammatory immune responses by protecting against oxidative stress in colitis
  Jiyoung Hwang, Jing Jin, Sejin Jeon, Shin Hye Moon, Min Young Park, Do-Young Yum, Jeong Hyun Kim, Ji-Eun Kang, Mi Hee Park, Eui-Joong Kim, Jae-Gu Pan, Oran Kwon, Goo Taeg Oh
  Redox Biology.2020; 37: 101760.     CrossRef
• Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment
  Loris Riccardo Lopetuso, Maddalena Corbi, Franco Scaldaferri, Valentina Petito, Cristina Graziani, Federica Castri, Matteo Neri, Antonio Gasbarrini, Alessandro Sgambato, Alfredo Papa
  European Journal of Gastroenterology & Hepatology.2020; 32(12): 1527.     CrossRef
• Gallic and butyric acids modulated NLRP3 inflammasome markers in a co-culture model of intestinal inflammation
  Ivan Luzardo-Ocampo, Guadalupe Loarca-Piña, Elvira Gonzalez de Mejia
  Food and Chemical Toxicology.2020; 146: 111835.     CrossRef
• Bioinformatics Analysis of Key Candidate Genes and Pathways in Ulcerative Colitis
  Guangya Xu, Xueling Yan, Jie Chen, Xiaoheng Guo, Xiaolan Guo, Yong Tang, Zheng Shi
  Biological and Pharmaceutical Bulletin.2020; 43(11): 1760.     CrossRef
• Therapeutic Effect of Mesenchymal Stem Cells in Ulcerative Colitis: A Review on Achievements and Challenges
  Seyed-Kazem Hosseini-Asl, Davood Mehrabani, Feridoun Karimi-Busheri
  Journal of Clinical Medicine.2020; 9(12): 3922.     CrossRef
• Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases
  Aristea Gioxari, Charalampia Amerikanou, Efstathia Papada, Evangelia Zioga, Andreas D. Georgoulis, George Bamias, Andriana C. Kaliora
  Nutrients.2020; 12(12): 3734.     CrossRef
• İnflamatuar Bağırsak Hastalıkları Olan Bireylerde İlaç Uyumu ve Yaşam Kalitesi
  Nazli ÖZTÜRK, Yasemin YILDIRIM
  Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi.2020; 2(3): 192.     CrossRef
• Nutritional Support and Probiotics as a Potential Treatment of IBD
  Aleksandra Tarasiuk, Guido Eibl
  Current Drug Targets.2020; 21(14): 1417.     CrossRef
• A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
  Ali N. Kamali, Seyedeh Masoomeh Noorbakhsh, Haleh Hamedifar, Farhad Jadidi-Niaragh, Reza Yazdani, José M. Bautista, Gholamreza Azizi
  Molecular Immunology.2019; 105: 107.     CrossRef
• 5‐Hydroxytryptamine (5‐HT)‐exacerbated DSS‐induced colitis is associated with elevated NADPH oxidase expression in the colon
  Shizhen Dong, Menglu Chen, Faliang Dai, Qingxia Xuan, Pan Chen, Dandan Feng, Lei Gao, Chendi Zhu, Yongchao Chang, Fong‐Fong Chu, Qiang Gao
  Journal of Cellular Biochemistry.2019; 120(6): 9230.     CrossRef
• pVAX1-A20 alleviates colitis in mice by promoting regulatory T cells
  Tianyong Hu, Wenhui Hu, Li Ma, Xianhai Zeng, Jiangqi Liu, Baohui Cheng, Pingchang Yang, Shuqi Qiu, Gui Yang, Donghui Chen, Zhiqiang Liu
  Digestive and Liver Disease.2019; 51(6): 790.     CrossRef
• Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
  Anniina T. Virtanen, Teemu Haikarainen, Juuli Raivola, Olli Silvennoinen
  BioDrugs.2019; 33(1): 15.     CrossRef
• Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Journal of Gastroenterology and Hepatology.2019; 34(7): 1166.     CrossRef
• Red wine extract preserves tight junctions in intestinal epithelial cells under inflammatory conditions: implications for intestinal inflammation
  Carla Nunes, Víctor Freitas, Leonor Almeida, João Laranjinha
  Food & Function.2019; 10(3): 1364.     CrossRef
• Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response
  Noymar Luque-Campos, Rafael A. Contreras-López, María Jose Paredes-Martínez, Maria Jose Torres, Sarah Bahraoui, Mingxing Wei, Francisco Espinoza, Farida Djouad, Roberto Javier Elizondo-Vega, Patricia Luz-Crawford
  Frontiers in Immunology.2019;[Epub]     CrossRef
• Risk of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Nationwide, Population-Based Study
  Kookhwan Choi, Jaeyoung Chun, Kyungdo Han, Seona Park, Hosim Soh, Jihye Kim, Jooyoung Lee, Hyun Lee, Jong Im, Joo Kim
  Journal of Clinical Medicine.2019; 8(5): 654.     CrossRef
• Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors
  Bruno Emond, Lorie A. Ellis, Soumya D. Chakravarty, Martin Ladouceur, Patrick Lefebvre
  Current Medical Research and Opinion.2019; 35(10): 1751.     CrossRef
• Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis model
  Young-Jae Hwang, Seung-Joo Nam, Wanjoo Chun, Song In Kim, Sung Chul Park, Chang Don Kang, Sung Joon Lee, Partha Mukhopadhyay
  PLOS ONE.2019; 14(5): e0217642.     CrossRef
• Micronutrient Absorption and Related Outcomes in People with Inflammatory Bowel Disease: A Review
  Kyle Kilby, Holly Mathias, Lindsay Boisvenue, Courtney Heisler, Jennifer L. Jones
  Nutrients.2019; 11(6): 1388.     CrossRef
• Therapeutic ultrasound attenuates DSS-induced colitis through the cholinergic anti-inflammatory pathway
  Natalia Schneider Nunes, Parwathy Chandran, Maggie Sundby, Fernanda Visioli, Fabiany da Costa Gonçalves, Scott Robert Burks, Ana Helena Paz, Joseph Alan Frank
  EBioMedicine.2019; 45: 495.     CrossRef
• Inflammatory bowel disease - glycomics perspective
  Maja Hanić, Irena Trbojević-Akmačić, Gordan Lauc
  Biochimica et Biophysica Acta (BBA) - General Subjects.2019; 1863(10): 1595.     CrossRef
• Genetic mapping of cell type specificity for complex traits
  Kyoko Watanabe, Maša Umićević Mirkov, Christiaan A. de Leeuw, Martijn P. van den Heuvel, Danielle Posthuma
  Nature Communications.2019;[Epub]     CrossRef
• Diet and Nutrition in IBD—Progress and Gaps
  Maitreyi Raman, Subrata Ghosh
  Nutrients.2019; 11(8): 1740.     CrossRef
• Comorbidities of hidradenitis suppurativa: A review of the literature
  Alexander Cartron, Marcia S. Driscoll
  International Journal of Women's Dermatology.2019; 5(5): 330.     CrossRef
• Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson’s Disease: A South Korean Nationwide Population-Based Study
  Seona Park, Jihye Kim, Jaeyoung Chun, Kyungdo Han, Hosim Soh, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim
  Journal of Clinical Medicine.2019; 8(8): 1191.     CrossRef
• Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers
  Xi-Xi Wu, Xie-Lin Huang, Ru-Ru Chen, Tang Li, Hua-Jun Ye, Wei Xie, Zhi-Ming Huang, Gao-Zhong Cao
  Inflammation.2019; 42(6): 2215.     CrossRef
• The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: fromin silicotoin vivo
  Shian-Ren Lin, Chia-Hsiang Chang, May-Jwan Tsai, Henrich Cheng, Jian-Chyi Chen, Max K. Leong, Ching-Feng Weng
  Therapeutic Advances in Chronic Disease.2019; 10: 204062231987530.     CrossRef
• Anti‐inflammatory effects of eriocitrin against the dextran sulfate sodium–induced experimental colitis in murine model
  Gang Guo, Wen Shi, Feiyu Shi, Wenqing Gong, Fanni Li, Guangju Zhou, Junjun She
  Journal of Biochemical and Molecular Toxicology.2019;[Epub]     CrossRef
• Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD
  Hong Liu, Suryasarathi Dasgupta, Yu Fu, Brandi Bailey, Christian Roy, Eric Lightcap, Benjamin Faustin
  BMC Immunology.2019;[Epub]     CrossRef
• Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
  Carl Randall Harrell, Nemanja Jovicic, Valentin Djonov, Nebojsa Arsenijevic, Vladislav Volarevic
  Cells.2019; 8(12): 1605.     CrossRef
• Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine
  Manoj Kumar, Mathieu Garand, Souhaila Al Khodor
  Journal of Translational Medicine.2019;[Epub]     CrossRef
• Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network)
  Hajime Yamazaki, Katsuyoshi Matsuoka, Jovelle Fernandez, Toshifumi Hibi, Mamoru Watanabe, Tadakazu Hisamatsu, Shunichi Fukuhara
  BMJ Open.2019; 9(9): e030134.     CrossRef
• Circular RNA expression alterations in colon tissues of Crohn's disease patients
  Yu Qiao, Chen Cai, Jun Shen, Qing Zheng, Zhi Ran
  Molecular Medicine Reports.2019;[Epub]     CrossRef
• Frondanol, a Nutraceutical Extract from Cucumaria frondosa, Attenuates Colonic Inflammation in a DSS-Induced Colitis Model in Mice
  Sandeep B. Subramanya, Sanjana Chandran, Saeeda Almarzooqi, Vishnu Raj, Aisha Salem Al Zahmi, Radeya Ahmed Al Katheeri, Samira Ali Al Zadjali, Peter D. Collin, Thomas E. Adrian
  Marine Drugs.2018; 16(5): 148.     CrossRef
• Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology
  Susanne Juhl Pedersen, Walter P. Maksymowych
  Drugs.2018; 78(14): 1397.     CrossRef
• Pleiotropic Immune Functions of Chemokine Receptor 6 in Health and Disease
  Ranmali Ranasinghe, Rajaraman Eri
  Medicines.2018; 5(3): 69.     CrossRef
• T-cell immune response against cytomegalovirus in peripheral blood and colonic mucosa from ulcerative colitis and Crohn's disease patients
  Seung-Joo Nam, Eun Sun Kim, Yoon Tae Jeen
  Intestinal Research.2018; 16(1): 160.     CrossRef
• CCR6–CCL20-Mediated Immunologic Pathways in Inflammatory Bowel Disease
  Ranmali Ranasinghe, Rajaraman Eri
  Gastrointestinal Disorders.2018; 1(1): 15.     CrossRef
• Vitamin A supplementation decreases disease activity index in patients with ulcerative colitis: A randomized controlled clinical trial
  Kourosh Masnadi Shirazi, Zeinab Nikniaz, Arman Masnadi Shirazi, Mohammadreza Rohani
  Complementary Therapies in Medicine.2018; 41: 215.     CrossRef
• CCR6–CCL20 Axis in IBD: What Have We Learnt in the Last 20 Years?
  Ranmali Ranasinghe, Rajaraman Eri
  Gastrointestinal Disorders.2018; 1(1): 57.     CrossRef
• Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
  Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim
  World Journal of Gastroenterology.2018; 24(42): 4798.     CrossRef
• Commensal Bacteria-Specific CD4+ T Cell Responses in Health and Disease
  Chiara Sorini, Rebeca F. Cardoso, Nicola Gagliani, Eduardo J. Villablanca
  Frontiers in Immunology.2018;[Epub]     CrossRef
• Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
  Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2018; 12(5): 544.     CrossRef
• Impact of Autophagy of Innate Immune Cells on Inflammatory Bowel Disease
  Tomoya Iida, Yoshihiro Yokoyama, Kohei Wagatsuma, Daisuke Hirayama, Hiroshi Nakase
  Cells.2018; 8(1): 7.     CrossRef
• IMMUNOREGULATORY PROFILE OF MICROSYMBIONTS OF THE INTESTINAL HUMAN BIOTOPE
  O. V. Bukharin, I. N. Chainikova, E. V. Ivanova, N. B. Perunova, T. A. Bondarenko, A. I. Smolyagin
  Journal of microbiology, epidemiology and immunobiology.2018; 95(4): 42.     CrossRef

Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic, debilitating, and expensive condition affecting millions of people globally. There is significant variation in the quality of care for patients with IBD across North America, Europe, and Asia; this variation suggests poor quality of care due to overuse, underuse, or misuse of health services and disparity of outcomes. Several initiatives have been developed to reduce variation in care delivery and improve processes of care, patient outcomes, and reduced healthcare costs. These initiatives include the development of quality indicator sets to standardize care across organizations, and learning health systems to enable data sharing between doctors and patients, and sharing of best practices among providers. These programs have been variably successful in improving patient outcomes and reducing healthcare utilization. Further studies are needed to demonstrate the long-term impact and applicability of these efforts in different geographic areas around the world, as regional variations in patient populations, societal preferences, and costs should inform local quality improvement efforts.

Citations

Citations to this article as recorded by  

• Development of a set of measurable outcome indicators for Flemish patients with inflammatory bowel disease
  Liselotte Fierens, Peter Bossuyt, Filip Baert, Didier Baert, Caroline Weltens, Marga Lavaerts, Kris Vanhaecht, Frank E. Rademakers, Marc Ferrante
  European Journal of Gastroenterology & Hepatology.2024; 36(9): 1075.     CrossRef
• Opioid Use and Outcomes in Patients Hospitalized With Acute Severe Ulcerative Colitis
  Norah Karlovich, Ryan McConnell, Fernando Velayos, Uma Mahadevan, Sara Lewin
  Inflammatory Bowel Diseases.2024;[Epub]     CrossRef
• Clinical outcomes amongst elderly patients with inflammatory bowel disease
  Vithoosharan Sivanathan, Chamara Basnayake, William Connell, Emily Wright, John Nik Ding, Ola Niewadomski, Annalise Stanley, Amy Wilson‐O'Brien, Stephanie Fry, Tamie Samyue, Mark Lust, Emma Flanagan, Alexander J. V. Thompson, Michael A. Kamm
  Internal Medicine Journal.2023; 53(10): 1866.     CrossRef
• Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease
  Chung Sang Tse, Aricca D Van Citters, Brittany Ricci, Noah Z Freundlich, Moses Lee, Samir A Shah, Gil Y Melmed, Corey A Siegel, Welmoed K van Deen, Christopher Almario, Rose Arrieta, Andrea Banty, Harry Bray, Catherine Bresee, Jessica Carron, Aline Charab
  Journal of Crohn's and Colitis.2022; 16(3): 379.     CrossRef
• Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review
  David I. Fudman, Andrea Escala Perez-Reyes, Blake A. Niccum, Gil Y. Melmed, Hamed Khalili
  Clinical Gastroenterology and Hepatology.2022; 20(9): 1947.     CrossRef
• Consenso latinoamericano acerca de indicadores de calidad para Clínicas de Atención Integral para pacientes con enfermedad inflamatoria intestinal: PANCCO-GETECCU
  J.K. Yamamoto-Furusho, D. Andrade, J. Barahona, S. Bautista, F. Bosques-Padilla, J. de Paula, M.T. Galiano, B. Iade, F. Juliao-Baños, G. Otoya, F. Steinwurz, E. Torres, G. Veitia, M. Barreiro-de Acosta
  Revista de Gastroenterología de México.2022; 87(1): 89.     CrossRef
• Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU
  J.K. Yamamoto-Furusho, D. Andrade, J. Barahona, S. Bautista, F. Bosques-Padilla, J. de Paula, M.T. Galiano, B. Iade, F. Juliao-Baños, G. Otoya, F. Steinwurz, E. Torres, G. Veitia, M. Barreiro-de Acosta
  Revista de Gastroenterología de México (English Edition).2022; 87(1): 89.     CrossRef
• Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease
  Jeremy Adler, Sally J Eder, Acham Gebremariam, Christopher J Moran, Lee M Bass, Jonathan Moses, Jeffery D Lewis, Andrew A M Singer, Tina L Morhardt, Joseph A Picoraro, Vanessa Cardenas, George M Zacur, Richard B Colletti
  Inflammatory Bowel Diseases.2022; 28(10): 1537.     CrossRef
• A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease
  Robert Battat, Jonathan S. Galati, Dana Lukin, Fatiha Chabouni, Robbyn Sockolow, Jeff Carter, Kristina Fajardo, Stevie Yang, Jenna Reich, Vinita Jacobs, Meira Abramowitz, Anand Kumar, Paul Christos, Randy S. Longman, Robert Burakoff, Laura Simone, Tamar S
  Journal of Clinical Gastroenterology.2022; 56(3): e176.     CrossRef
• Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center
  Shen Jun, Liang Jie, Mao Ren, Ran Zhihua
  Inflammatory Bowel Diseases.2022; 28(Supplement): S3.     CrossRef
• Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn’s Disease
  Anuj Bohra, Abhinav Vasudevan, Numan Kutaiba, Daniel R. Van Langenberg
  Diagnostics.2022; 12(10): 2533.     CrossRef
• Are Quality Metrics in Inflammatory Bowel Disease Rooted in Substantial Quality Evidence? A Systematic Review
  Simcha Weissman, Alexander Goldowsky, Tej I Mehta, Michael A Sciarra, Joseph D Feuerstein
  Journal of Crohn's and Colitis.2021; 15(2): 326.     CrossRef
• Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes
  Simon J. Hong, Janice Jang, Dana Berg, Tarik Kirat, Feza Remzi, Shannon Chang, Lisa B. Malter, Jordan E. Axelrad, David P. Hudesman
  Digestive Diseases and Sciences.2021; 66(11): 3753.     CrossRef
• Identifying and Predicting the Goals and Concerns of Individuals with Inflammatory Bowel Disease
  Chung Sang Tse, Aricca D. Van Citters, Brittany Ricci, Noah Z. Freundlich, Moses Lee, Samir A. Shah, Gil Y. Melmed, Corey A. Siegel, Welmoed K. van Deen
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• Subjective Needs and Thoughts for the Treatment of Patients with Inflammatory Bowel Disease: Applying Q Methodology
  Yong Eun Park, Jin Lee, Jongha Park, Joon Hyuk Choi, Nae Yun Heo, Seung Ha Park, Yoon Kyoung Lee, Tae Oh Kim
  The Korean Journal of Gastroenterology.2021; 78(1): 37.     CrossRef
• The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care
  Jonathan A. Beard, Diana L. Franco, Benjamin H. Click
  Current Gastroenterology Reports.2020;[Epub]     CrossRef
• Opioid Use in Patients With Inflammatory Bowel Disease
  Xiwu Lin, Jennifer Lofland, Ling Zhang, Sheldon Sloan, Laila Chamaa, Colleen Marano, Scott Plevy
  Crohn's & Colitis 360.2020;[Epub]     CrossRef
• The burden of cost in inflammatory bowel disease: a medical economic perspective
  Jonathan A. Beard, Benjamin H. Click
  Current Opinion in Gastroenterology.2020; 36(4): 310.     CrossRef

• New Zealand National Audit of Outpatient Inflammatory Bowel Disease Standards of Care

  
  Robert Hackett, Richard Gearry, Christine Ho, Andrew McCombie, Megan Mackay, Karen Murdoch, Kirsten Rosser, Nideen Visesio, Stephen Inns
  Clinical and Experimental Gastroenterology.2020; Volume 13: 285.     CrossRef
• Improving the quality of care for inflammatory bowel disease
  Byong Duk Ye, Simon Travis
  Intestinal Research.2019; 17(1): 45.     CrossRef
• Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Journal of Gastroenterology and Hepatology.2019; 34(7): 1166.     CrossRef
• The Inflammatory Bowel Disease Medical Home: From Patients to Populations
  Benjamin Click, Miguel Regueiro
  Inflammatory Bowel Diseases.2019; 25(12): 1881.     CrossRef
• Medication non-adherence in inflammatory bowel diseases is associated with disability
  Jonathan Perry, Andy Chen, Viraj Kariyawasam, Glen Collins, Chee Choong, Wei Ling Teh, Nikola Mitrev, Friedbert Kohler, Rupert Wing Loong Leong
  Intestinal Research.2018; 16(4): 571.     CrossRef
• Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
  Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim
  World Journal of Gastroenterology.2018; 24(42): 4798.     CrossRef

Colonoscopy is currently regarded as the gold standard and preferred method of screening for colorectal cancer (CRC). However, the benefit of colonoscopy screening may be blunted by low participation rates in population-based screening programs. Harmful effects of population-based colonoscopy screening may include complications induced by colonoscopy itself and by sedation, psychosocial distress, potential over-diagnosis, and socioeconomic burden. In addition, harmful effects of colonoscopy may increase with age and comorbidities. As the risk of adverse events in population-based colonoscopy screening may offset the benefit, the adverse events should be managed and monitored. To adopt population-based colonoscopy screening, consensus on the risks and benefits should be developed, focusing on potential harm, patient preference, socioeconomic considerations, and quality improvement of colonoscopy, as well as efficacy for CRC prevention. As suboptimal colonoscopy quality is a major pitfall of population-based screening, adequate training and regulation of screening colonoscopists should be the first step in minimizing variations in quality. Gastroenterologists should promote quality improvement, auditing, and training for colonoscopy in a population-based screening program.

Citations

Citations to this article as recorded by  

• Evaluation of the “Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing” (B-PREDICT)—a population-based colorectal cancer screening program
  Stefanie BREZINA, Gernot LEEB, Andreas BAIERL, Evelyn GRÄF, Monika HACKL, Philipp HOFER, Harald LANG, Michaela KLEIN, Karl MACH, Remy SCHWARZER, Wilhelm WLASSITS, Andreas PÜSPÖK, Andrea GSUR
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Strategies to improve screening colonoscopy quality for the prevention of colorectal cancer
  Joo Hye Song, Eun Ran Kim
  The Korean Journal of Internal Medicine.2024; 39(4): 547.     CrossRef
• The adult large bowel: describing environment morphology for effective biomedical device development
  Joseph C Norton, James W Martin, Conchubhair Winters, Bruno Scaglioni, Keith L Obstein, Venkataraman Subramanian, Pietro Valdastri
  Progress in Biomedical Engineering.2024; 6(3): 032003.     CrossRef
• Efficacy of colonoscopic re-examination across the entire colon: a randomized controlled trial
  Dong Seok Lee, Jeong-Seon Ji, Tae-Geun Gweon, Myeongsook Seo, Hwang Choi
  Surgical Endoscopy.2024;[Epub]     CrossRef
• Comment on " Positive fecal immunochemical test results are associated with non-colorectal cancer mortality"
  Yong Eun Park
  The Korean Journal of Internal Medicine.2023; 38(2): 264.     CrossRef
• Challenges and Suggestions in the Management of Stomach and Colorectal Cancer in Uzbekistan: The Third Report of the Uzbekistan–Korea Oncology Consortium
  Chai Hong Rim, Won Jae Lee, Odiljon Akhmedov, Ulugbek Sabirov, Yakov Ten, Yakhyo Ziyayev, Mirzagaleb Tillyashaykhov, Jae Suk Rim
  International Journal of Environmental Research and Public Health.2023; 20(8): 5477.     CrossRef
• Gastrointestinal cancer prevention policies: A qualitative systematic review and meta-synthesis
  Neda Kabiri, Rahim Khodayari-zarnaq, Manouchehr Khoshbaten, Ali Janati
  International Journal of Preventive Medicine.2022; 13(1): 8.     CrossRef
• Quality indicators in colonoscopy: the chasm between ideal and reality
  Su Bee Park, Jae Myung Cha
  Clinical Endoscopy.2022; 55(3): 332.     CrossRef
• Effect of prophylactic clip application for the prevention of postpolypectomy bleeding of large pedunculated colonic polyps: a randomized controlled trial
  Tae-Geun Gweon, Kang-Moon Lee, Seung-Woo Lee, Dae Bum Kim, Jeong-Seon Ji, Ji Min Lee, Woo Chul Chung, Chang-Nyol Paik, Hwang Choi
  Gastrointestinal Endoscopy.2021; 94(1): 148.     CrossRef
• Comparison of adenoma detection by colonoscopy between polypectomy performed during both insertion and withdrawal versus during withdrawal only: a multicenter, randomized, controlled trial
  Tae-Geun Gweon, Seung-Woo Lee, Jeong-Seon Ji, Jeong Rok Lee, Joon Sung Kim, Byung-Wook Kim, Hwang Choi
  Surgical Endoscopy.2020; 34(12): 5461.     CrossRef
• Strategies to Increase the Participation Rate of Colorectal Cancer Screening
  Yoon Suk Jung
  Gut and Liver.2020; 14(3): 277.     CrossRef
• UEG Week 2018 Poster Presentations
  
  United European Gastroenterology Journal.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis
  Michael Youssef, Kelly Dong, So Jeong Lee, Neeraj Narula
  Inflammatory Bowel Diseases.2024; 30(1): 125.     CrossRef
• Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
  Mohammad Shehab, Sahad Al Akram, Amro Hassan, Fatema Alrashed, Vipul Jairath, Talat Bessissow
  Inflammatory Bowel Diseases.2024; 30(4): 563.     CrossRef
• Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus
  Ferdinando D’Amico, Fernando Magro, Britta Siegmund, Taku Kobayashi, Paulo Gustavo Kotze, Virginia Solitano, Benedicte Caron, Sameer Al Awadhi, Ailsa Hart, Vipul Jairath, Axel Dignass, Laurent Peyrin-Biroulet, Silvio Danese
  Inflammatory Bowel Diseases.2024; 30(6): 1009.     CrossRef
• Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib
  Sara van Gennep, Ivan C N Fung, Djuna C de Jong, Rishand K Ramkisoen, Esmé Clasquin, Jitteke de Jong, Leonie C S de Vries, Wouter J de Jonge, Krisztina B Gecse, Mark Löwenberg, John C Woolcott, Aart Mookhoek, Geert R D’Haens
  Journal of Crohn's and Colitis.2024; 18(8): 1283.     CrossRef
• Etrolizumab as an induction and maintenance therapy for ulcerative colitis: A systematic review and meta‐analysis of randomized controlled trials
  Othman Saleh, Mohamed T. Abuelazm, Islam Mohamed, Alaa Ramadan, Mohammad Assaf, Ahmad Alzoubi, Majd M. AlBarakat, Basel Abdelazeem
  JGH Open.2024;[Epub]     CrossRef
• Advanced Endoscopic Imaging for Assessing Mucosal Healing and Histologic Remission in Inflammatory Bowel Diseases
  Tommaso Pessarelli, Gian Eugenio Tontini, Helmut Neumann
  Gastrointestinal Endoscopy Clinics of North America.2024;[Epub]     CrossRef
• Adequacy of sigmoidoscopy as compared to colonoscopy for assessment of disease activity in patients of ulcerative colitis: a prospective study
  Sameet Tariq Patel, Anuraag Jena, Sanjay Chandnani, Shubham Jain, Pankaj Nawghare, Saurabh Bansal, Harsh Gandhi, Rishikesh Malokar, Jay Chudasama, Prasanta Debnath, Seemily Kahmei, Rima Kamat, Sangeeta Kini, Qais Q Contractor, Pravin M Rathi
  Intestinal Research.2024; 22(3): 310.     CrossRef
• Deep mucosal healing in ulcerative colitis: how deep is better?
  Xin Jin, Yan You, Gechong Ruan, Weixun Zhou, Ji Li, Jingnan Li
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Histologic improvement predicts endoscopic remission in patients with ulcerative colitis
  Ji Eun Kim, Minjee Kim, Min-Ji Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Sang Yun Ha, Young-Ho Kim
  Scientific Reports.2024;[Epub]     CrossRef
• Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1
  Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim
  Inflammatory Bowel Diseases.2023; 29(2): 238.     CrossRef
• (Re)Appraising Remission in Ulcerative Colitis
  Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Charles N Bernstein, David T Rubin
  Inflammatory Bowel Diseases.2023; 29(8): 1317.     CrossRef
• Artificial Intelligence Enables Quantitative Assessment of Ulcerative Colitis Histology
  Fedaa Najdawi, Kathleen Sucipto, Pratik Mistry, Stephanie Hennek, Christina K.B. Jayson, Mary Lin, Darren Fahy, Shawn Kinsey, Ilan Wapinski, Andrew H. Beck, Murray B. Resnick, Archit Khosla, Michael G. Drage
  Modern Pathology.2023; 36(6): 100124.     CrossRef
• Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease
  Stefan Chiriac, Catalin Victor Sfarti, Horia Minea, Carol Stanciu, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Tudor Cuciureanu, Oana Petrea, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia, Robert Nastasa, Remus Stafie, Adrian Rotaru, Er
  Diagnostics.2023; 13(7): 1230.     CrossRef
• HISTOPATHOLOGICAL FEATURES IN RELAPSE OF ULCERATIVE COLITIS.
  Saroash Iqbal, Aman Ur Rehman, Nausheen Henna, Zara Madiha, Sahar Moeed, Uzma Aslam
  JAIMC: Journal of Allama Iqbal Medical College.2023;[Epub]     CrossRef
• Mucosal Atrophy Predicts Poorer Outcomes in Pediatric Ulcerative Colitis—A National Inception Cohort Study
  Emily Stenke, Lorraine Stallard, Sarah Cooper, Anna Dominik, Abigail Pilkington, Sheila Sugrue, Maureen O’Sullivan, Michael McDermott, Shoana Quinn, Annemarie Broderick, Billy Bourke, Séamus Hussey
  Journal of Pediatric Gastroenterology & Nutrition.2023; 76(5): 603.     CrossRef
• Automating Ground Truth Annotations for Gland Segmentation Through Immunohistochemistry
  Tushar Kataria, Saradha Rajamani, Abdul Bari Ayubi, Mary Bronner, Jolanta Jedrzkiewicz, Beatrice S. Knudsen, Shireen Y. Elhabian
  Modern Pathology.2023; 36(12): 100331.     CrossRef
• Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing
  Alina Ecaterina Jucan, Otilia Gavrilescu, Mihaela Dranga, Iolanda Valentina Popa, Ioana-Ruxandra Mihai, Vasile-Claudiu Mihai, Gabriela Stefanescu, Vasile Liviu Drug, Cristina Cijevschi Prelipcean, Radu-Alexandru Vulpoi, Oana-Bogdana Barboi, Irina Ciortesc
  Biomedicines.2023; 11(11): 3090.     CrossRef
• Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease
  Barbara Sosna, David Aebisher, Angelika Myśliwiec, Klaudia Dynarowicz, Dorota Bartusik-Aebisher, Piotr Oleś, Grzegorz Cieślar, Aleksandra Kawczyk-Krupka
  International Journal of Molecular Sciences.2023; 25(1): 202.     CrossRef
• Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis
  Niels Vande Casteele, Jonathan A Leighton, Shabana F Pasha, Frank Cusimano, Aart Mookhoek, Catherine E Hagen, Christophe Rosty, Reetesh K Pai, Rish K Pai
  Inflammatory Bowel Diseases.2022; 28(4): 539.     CrossRef
• Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis
  Silvio Danese, Barrett G. Levesque, Brian G. Feagan, Alina Jucov, Bal Raj Bhandari, Rish K. Pai, Kristen Taylor Meadows, Brian J. Kirby, Jean‐Marie Bruey, Allan Olson, Robin Osterhout, Courtney Van Biene, Julia Ford, Richard Aranda, Kartik Raghupathi, Wil
  Alimentary Pharmacology & Therapeutics.2022; 55(4): 401.     CrossRef
• PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system
  Xianyong Gui, Alina Bazarova, Rocìo del Amor, Michael Vieth, Gert de Hertogh, Vincenzo Villanacci, Davide Zardo, Tommaso Lorenzo Parigi, Elin Synnøve Røyset, Uday N Shivaji, Melissa Anna Teresa Monica, Giulio Mandelli, Pradeep Bhandari, Silvio Danese, Jos
  Gut.2022; 71(5): 889.     CrossRef
• Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
  Angelo Viscido, Marco Valvano, Gianpiero Stefanelli, Annalisa Capannolo, Chiara Castellini, Eugenia Onori, Antonio Ciccone, Filippo Vernia, Giovanni Latella
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Appendiceal Orifice Inflammation Is Associated with Lower Rate of Complete Endoscopic Remission in Patients with Ulcerative Colitis
  Chang Kyo Oh, Han Hee Lee, Jin Su Kim, Bo-In Lee, Young-Seok Cho
  Journal of Personalized Medicine.2022; 12(5): 748.     CrossRef
• ECCO Position on Harmonisation of Crohn’s Disease Mucosal Histopathology
  F Magro, J Sabino, F Rosini, M Tripathi, P Borralho, P Baldin, S Danese, A Driessen, I O Gordon, M Iacucci, N Noor, M Svrcek, L Peyrin-Biroulet, R Feakins
  Journal of Crohn's and Colitis.2022; 16(6): 876.     CrossRef
• Constrained multiple instance learning for ulcerative colitis prediction using histological images
  Rocío del Amor, Pablo Meseguer, Tommaso Lorenzo Parigi, Vincenzo Villanacci, Adrián Colomer, Laëtitia Launet, Alina Bazarova, Gian Eugenio Tontini, Raf Bisschops, Gert de Hertogh, Jose G. Ferraz, Martin Götz, Xianyong Gui, Bu’Hussain Hayee, Mark Lazarev,
  Computer Methods and Programs in Biomedicine.2022; 224: 107012.     CrossRef
• Ulcerative colitis: Impact of early disease clearance on long‐term outcomes ‐ A multicenter cohort study
  Ferdinando D’Amico, Gionata Fiorino, Virginia Solitano, Eugenia Massarini, Lucas Guillo, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Stefanos Bonovas, Fernando Magro, Laurent Peyrin‐Biroulet, Silvio Danese
  United European Gastroenterology Journal.2022; 10(7): 775.     CrossRef
• Efficacy and safety of ozanimod for ulcerative colitis (review)
  M. V. Shapina, A. V. Poletova, T. A. Baranova
  Koloproktologia.2022; 21(3): 119.     CrossRef
• Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission
  Jun Ohara, Tetsuo Nemoto, Yasuharu Maeda, Noriyuki Ogata, Shin-ei Kudo, Toshiko Yamochi
  Journal of Gastroenterology.2022; 57(12): 962.     CrossRef
• Clinical Predictors of Response to Faecal Microbiota Transplantation in Patients with Active Ulcerative Colitis
  Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Kirandeep Kaur, Dharmatma Singh, Namita Bansal, Khushdeep Dharni
  Journal of Crohn's and Colitis.2021; 15(2): 238.     CrossRef
• Therapeutic drug monitoring of anti‐tumour necrosis factor‐α agents in inflammatory bowel disease: Limits and improvements
  José María Giráldez‐Montero, Jaime Gonzalez‐Lopez, Manuel Campos‐Toimil, María Jesús Lamas‐Díaz
  British Journal of Clinical Pharmacology.2021; 87(5): 2216.     CrossRef
• Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy
  Fernando Magro, Catarina Alves, Joanne Lopes, Susana Lopes, Helena Tavares de Sousa, José Cotter, Vitor Macedo da Silva, Paula Lago, Ana Vieira, Mariana Brito, Maria A.M. Duarte, Francisco Portela, João P. Silva, Paula Ministro, Bruno Arroja, Liliana Carv
  Clinical Gastroenterology and Hepatology.2021; 19(12): 2567.     CrossRef
• Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
  Akshita Gupta, Amy Yu, Laurent Peyrin-Biroulet, Ashwin N. Ananthakrishnan
  Clinical Gastroenterology and Hepatology.2021; 19(9): 1800.     CrossRef
• Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
  Ludimilla dos Reis Malvão, Kalil Madi, Barbara Cathalá Esberard, Renata Fernandes de Amorim, Kelly dos Santos Silva, Katia Farias e Silva, Heitor Siffert Pereira de Souza, Ana Teresa Pugas Carvalho
  Medicine.2021; 100(3): e24058.     CrossRef
• Real-life evaluation of histologic scores for Ulcerative Colitis in remission
  Christian Børde Arkteg, Sveinung Wergeland Sørbye, Lene Buhl Riis, Stig Manfred Dalen, Jon Florholmen, Rasmus Goll, Valérie Pittet
  PLOS ONE.2021; 16(3): e0248224.     CrossRef
• Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study
  William J Sandborn, Brian G Feagan, Stephen Hanauer, Severine Vermeire, Subrata Ghosh, Wenzhong J Liu, AnnKatrin Petersen, Lorna Charles, Vivian Huang, Keith Usiskin, Douglas C Wolf, Geert D’Haens
  Journal of Crohn's and Colitis.2021; 15(7): 1120.     CrossRef
• Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
  Marietta Iacucci, Louisa Jeffery, Animesh Acharjee, Olga Maria Nardone, Davide Zardo, Samuel C L Smith, Alina Bazarova, Rosanna Cannatelli, Uday N Shivaji, John Williams, Georgios Gkoutos, Subrata Ghosh
  Inflammatory Bowel Diseases.2021; 27(11): 1719.     CrossRef
• Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease
  Samuel C. L. Smith, Carl Banbury, Davide Zardo, Rosanna Cannatelli, Olga M. Nardone, Uday N. Shivaji, Subrata Ghosh, Pola Goldberg Oppenheimer, Marietta Iacucci, Pradeep Dudeja
  PLOS ONE.2021; 16(6): e0252210.     CrossRef
• Accurate diagnosis of endoscopic mucosal healing in ulcerative colitis using deep learning and machine learning
  Tien-Yu Huang, Shan-Quan Zhan, Peng-Jen Chen, Chih-Wei Yang, Henry Horng-Shing Lu
  Journal of the Chinese Medical Association.2021; 84(7): 678.     CrossRef
• Is histological remission of ulcerative colitis achievable?
  Oleg V. Knyazev, Anna V. Kagramanova, Sergei G. Khomeriki, Asfold I. Parfenov
  Terapevticheskii arkhiv.2021; 93(8): 975.     CrossRef
• Current Trends in IBD—Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System
  Yunki Y Yau, Valerie C Wasinger, Robert P Hirten, Emil Chuang, Merodean Huntsman, Jack Stylli, Jeff Shimizu, Vijay Yajnik, Jeffrey Smith, Shaoying N Lee, Sharat Singh, Christopher Wahl, Rupert W Leong, Bruce E Sands
  Inflammatory Bowel Diseases.2021; 27(Supplement): S17.     CrossRef
• Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy
  Oleg V. Knyazev, Sergey G. Khomeriki, Аnna V. Kagramanova, Albina A. Lishchinskaya, Olga A. Smirnova, Karina K. Noskova, Asfold I. Parfenov
  Terapevticheskii arkhiv.2021; 93(12): 1435.     CrossRef
• Histologic Activity and Steroid Use History are Risk Factors of Clinical Relapse in Ulcerative Colitis with Endoscopic Remission
  Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• Relationship between Mayo endoscopic score and histological scores in ulcerative colitis: A prospective study
  Jimil Shah, Usha Dutta, Ashim Das, Vishal Sharma, Harshal Mandavdhare, Pankaj Sharma, Dimple Kalsi, Priyanka Popli, Rakesh Kochhar
  JGH Open.2020; 4(3): 382.     CrossRef
• Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis
  Rish K. Pai, Douglas J. Hartman, Claudia Ramos Rivers, Miguel Regueiro, Marc Schwartz, David G. Binion, Reetesh K. Pai
  Clinical Gastroenterology and Hepatology.2020; 18(11): 2510.     CrossRef
• Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
  Natsuki Ishida, Takahiro Miyazu, Ryosuke Takano, Satoshi Tamura, Shinya Tani, Takuma Kagami, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Hiroaki Miyajima, Ken Sugimoto
  BMC Gastroenterology.2020;[Epub]     CrossRef
• ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
  Fernando Magro, Glen Doherty, Laurent Peyrin-Biroulet, Magali Svrcek, Paula Borralho, Alissa Walsh, Fatima Carneiro, Francesca Rosini, Gert de Hertogh, Luc Biedermann, Lieven Pouillon, Michael Scharl, Monika Tripathi, Silvio Danese, Vincenzo Villanacci, R
  Journal of Crohn's and Colitis.2020; 14(11): 1503.     CrossRef
• Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment
  Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa
  European Journal of Gastroenterology & Hepatology.2020; 32(9): 1091.     CrossRef
• What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
  Jongbeom Shin, Sung Min Kong, Gyeol Seong, Young-Ho Kim
  International Journal of Colorectal Disease.2020; 35(12): 2249.     CrossRef
• Treat to target or ‘treat to clear’ in inflammatory bowel diseases: one step further?
  Arianna Dal Buono, Giulia Roda, Marjorie Argollo, Eirini Zacharopoulou, Laurent Peyrin-Biroulet, Silvio Danese
  Expert Review of Gastroenterology & Hepatology.2020; 14(9): 807.     CrossRef
• Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis
  Hyuk Yoon, Sushrut Jangi, Parambir S. Dulai, Brigid S. Boland, Larry J. Prokop, Vipul Jairath, Brian G. Feagan, William J. Sandborn, Siddharth Singh
  Gastroenterology.2020; 159(4): 1262.     CrossRef
• Assessing Severity of Disease in Patients with Ulcerative Colitis
  Baldeep Singh Pabla, David Allen Schwartz
  Gastroenterology Clinics of North America.2020; 49(4): 671.     CrossRef
• Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
  Ajit Sood, Vineet Ahuja, Vandana Midha, Saroj Kant Sinha, C. Ganesh Pai, Saurabh Kedia, Varun Mehta, Sawan Bopanna, Philip Abraham, Rupa Banerjee, Shobna Bhatia, Karmabir Chakravartty, Sunil Dadhich, Devendra Desai, Manisha Dwivedi, Bhabhadev Goswami, Kir
  Intestinal Research.2020; 18(4): 355.     CrossRef
• ‘Treat to Target’ in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy
  Arianna Dal Buono, Giulia Roda, Marjorie Argollo, Kristine Paridaens, Laurent Peyrin-Biroulet, Silvio Danese
  Current Drug Targets.2020; 22(1): 117.     CrossRef
• What is the role of histopathology in the evaluation of disease activity in Crohn’s Disease?
  Rish K. Pai, Vipul Jairath
  Best Practice & Research Clinical Gastroenterology.2019;[Epub]     CrossRef
• Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis
  Lieven Pouillon, Hélène Rousseau, Hélène Busby-Venner, Marcelo De Carvalho Bittencourt, Myriam Choukour, Guillaume Gauchotte, Camille Zallot, Silvio Danese, Cédric Baumann, Laurent Peyrin-Biroulet
  Journal of Crohn's and Colitis.2019; 13(8): 970.     CrossRef
• Prediction of treatment outcome and relapse in inflammatory bowel disease
  Jun Kato, Takeichi Yoshida, Sakiko Hiraoka
  Expert Review of Clinical Immunology.2019; 15(6): 667.     CrossRef
• Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study
  Ajit Sood, Ramit Mahajan, Arshdeep Singh, Vandana Midha, Varun Mehta, Vikram Narang, Tarundeep Singh, Anmol Singh Pannu
  Journal of Crohn's and Colitis.2019; 13(10): 1311.     CrossRef
• Mucosal healing in inflammatory bowel disease: Expanding horizon
  Jimil Shah, Manik Lal Thakur, Usha Dutta
  Indian Journal of Gastroenterology.2019; 38(2): 98.     CrossRef
• A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review
  Ryan Ungaro, Jean-Frédéric Colombel, Trevor Lissoos, Laurent Peyrin-Biroulet
  American Journal of Gastroenterology.2019; 114(6): 874.     CrossRef
• A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials
  Katherine Li, Richard Strauss, Colleen Marano, Linda E Greenbaum, Joshua R Friedman, Laurent Peyrin-Biroulet, Carrie Brodmerkel, Gert De Hertogh
  Journal of Crohn's and Colitis.2019; 13(8): 1025.     CrossRef
• Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?
  Olga Maria Nardone, Rosanna Cannatelli, Davide Zardo, Subrata Ghosh, Iacucci Marietta
  Therapeutic Advances in Gastroenterology.2019; 12: 175628481986301.     CrossRef
• The emerging role of histologic disease activity assessment in ulcerative colitis
  Rish K. Pai, Vipul Jairath, Niels Vande Casteele, Florian Rieder, Claire E. Parker, Gregory Y. Lauwers
  Gastrointestinal Endoscopy.2018; 88(6): 887.     CrossRef
• Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis
  Natalia Schneider Nunes, Saejeong Kim, Maggie Sundby, Parwathy Chandran, Scott Robert Burks, Ana Helena Paz, Joseph Alan Frank
  World Journal of Gastroenterology.2018; 24(38): 4341.     CrossRef
• Can histologic remission be a better prognostic factor and therapeutic target beyond endoscopic mucosal healing in patients with ulcerative colitis?
  Hyo Jun Ahn, Sang-Bum Kang
  Intestinal Research.2018; 16(1): 1.     CrossRef

Citations

Citations to this article as recorded by  

• Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America
  Domingo Balderramo, Abel Botelho Quaresma, Pablo A Olivera, Mariane Christina Savio, Maria Paz Gimenez Villamil, Remo Panaccione, Siew C Ng, Gilaad G Kaplan, Paulo Gustavo Kotze
  The Lancet Gastroenterology & Hepatology.2024; 9(3): 263.     CrossRef
• Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
  Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, Joseph D. Feuerstein
  Intestinal Research.2022; 20(1): 72.     CrossRef
• Establishing a rabbit model of perianal fistulizing Crohn’s disease
  Shuang-Shuang Lu, Wen-Jia Liu, Qiu-Ya Niu, Chun-Yan Huo, Yu-Qing Cheng, En-Jing Wang, Rong-Nan Li, Fang-Fang Feng, Yi-Ming Cheng, Rong Liu, Jin Huang
  World Journal of Gastroenterology.2022; 28(15): 1536.     CrossRef
• Modern surgical strategies for perianal Crohn's disease
  Gilmara Pandolfo Zabot, Ornella Cassol, Rogerio Saad-Hossne, Willem Bemelman
  World Journal of Gastroenterology.2020; 26(42): 6572.     CrossRef
• Increased prevalence of anti‐TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood
  James J. Ashton, Florina Borca, Enrico Mossotto, Tracy Coelho, Akshay Batra, Nadeem A. Afzal, Hang T. T. Phan, Michael Stanton, Sarah Ennis, Robert Mark Beattie
  Alimentary Pharmacology & Therapeutics.2019; 49(4): 398.     CrossRef
• Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn’s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study
  Roy Frei, Nicolas Fournier, Jonas Zeitz, Michael Scharl, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann
  Journal of Crohn's and Colitis.2019; 13(10): 1292.     CrossRef
• Are Surgical Rates Decreasing in the Biological Era In IBD?
  Francesca Di Candido, Gionata Fiorino, Marco Spadaccini, Silvio Danese, Antonino Spinelli
  Current Drug Targets.2019; 20(13): 1356.     CrossRef

Citations

Citations to this article as recorded by  

• Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response
  Alex Adams, Vipin Gupta, Waled Mohsen, Thomas P Chapman, Deloshaan Subhaharan, Pradeep Kakkadasam Ramaswamy, Sudheer Kumar, Saurabh Kedia, Colleen GC McGregor, Tim Ambrose, Bruce D George, Rebecca Palmer, Oliver Brain, Alissa Walsh, Vineet Ahuja, Simon P
  Gut.2023; 72(3): 433.     CrossRef
• Inflammatory bowel disease: An Indian perspective
  Mayank Jain, Jayanthi Venkataraman
  Indian Journal of Medical Research.2021; 153(4): 421.     CrossRef
• High Serum Osmolality May Predict the Disease Severity in Patients with Acute Ulcerative Colitis
  Abdussamed VURAL, Aslı VURAL, Selahattin VURAL, Selim TURFAN, Ahmet Cumhur DÜLGER
  Online Türk Sağlık Bilimleri Dergisi.2020; 5(2): 324.     CrossRef

• Relationship Between Vitamin D Deficiency and Disease Activity in Patients with Inflammatory Bowel Disease in Ahvaz, Iran

  
  Esmat Rasouli, Narges Sadeghi, Abazar Parsi, Seyed Jalal Hashemi, Morteza Nayebi, Aliakbar Shayesteh
  Clinical and Experimental Gastroenterology.2020; Volume 13: 419.     CrossRef
• A current overview of corticosteroid use in active ulcerative colitis
  Marco Salice, Fernando Rizzello, Carlo Calabrese, Lucia Calandrini, Paolo Gionchetti
  Expert Review of Gastroenterology & Hepatology.2019; 13(6): 557.     CrossRef
• Optimal management of acute severe ulcerative colitis
  Saransh Jain, Vineet Ahuja, Jimmy K Limdi
  Postgraduate Medical Journal.2019; 95(1119): 32.     CrossRef
• A challenge in diagnosis and management of ulcerative colitis in elderly patient with atypical presentation: A reported case
  Panutchaya Kongon, Vorapatu Tangsirapat, Vittawat Ohmpornuwat, Kannakrit Sumtong, Vichack Chakrapan Na Ayudhya, Kobkool Chakrapan Na Ayudhya, Paiboon Sookpotarom, Paisarn Vejchapipat
  International Journal of Surgery Case Reports.2019; 61: 234.     CrossRef

Citations

Citations to this article as recorded by  

• Common Mistakes in Managing Patients with Inflammatory Bowel Disease
  Javier P. Gisbert, María Chaparro
  Journal of Clinical Medicine.2024; 13(16): 4795.     CrossRef
• Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease
  Javier P. Gisbert, María Chaparro
  Drugs.2023; 83(13): 1179.     CrossRef
• Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease
  Marco Valvano, Annalisa Capannolo, Nicola Cesaro, Gianpiero Stefanelli, Stefano Fabiani, Sara Frassino, Sabrina Monaco, Marco Magistroni, Angelo Viscido, Giovanni Latella
  Nutrients.2023; 15(17): 3824.     CrossRef
• Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events
  Mitchell R. K. L. Lie, Emma Paulides, C. Janneke van der Woude
  International Journal of Colorectal Disease.2020; 35(8): 1489.     CrossRef
• Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry
  Fiorella Cañete, Míriam Mañosa, María José Casanova, Ramiro C González-Sueyro, Jesús Barrio, Fernando Bermejo, Pilar Nos, Eva Iglesias-Flores, Esther García-Planella, José Lázaro Pérez-Calle, Raquel Vicente, Maribel Vera, Laura Ramos, Montserrat Rivero, R
  Inflammatory Bowel Diseases.2019; 25(11): 1862.     CrossRef
• Maneuvering Clinical Pathways for Crohn’s Disease
  Thomas X. Lu, Russell D. Cohen
  Current Gastroenterology Reports.2019;[Epub]     CrossRef
• Author's Reply
  Sakiko Hiraoka, Jun Kato, Hiroyuki Okada
  Intestinal Research.2018; 16(2): 321.     CrossRef
• The old versus the new: which do you keep in postoperative Crohn's disease?
  Paulo Gustavo Kotze, Christopher Ma, Miguel Regueiro, Remo Panaccione
  Intestinal Research.2018; 16(2): 319.     CrossRef

Citations

Citations to this article as recorded by  

• Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
  Antonio Tursi, Giammarco Mocci, Leonardo Allegretta, Giovanni Aragona, Maria Antonia Bianco, Raffaele Colucci, Antonio Cuomo, Nicola Della Valle, Antonio Ferronato, Giacomo Forti, Federica Gaiani, GianMarco Giorgetti, Maria Giovanna Graziani, Katia Lofano
  Inflammatory Bowel Diseases.2023; 29(3): 376.     CrossRef
• Crohn’s Disease Among the Poorest Billion: Burden of Crohn’s Disease in Low- and Lower-Middle-Income Countries
  Ruma Rajbhandari, Samantha Blakemore, Neil Gupta, Sara Mannan, Klejda Nikolli, Alison Yih, Laura Drown, Gene Bukhman
  Digestive Diseases and Sciences.2023; 68(4): 1226.     CrossRef
• The Long-Term Effects of Short-Period Adalimumab Biosimilar Usage in Ankylosing Spondylitis
  Arvind Chopra, Nagnath Khadke, Manjit Saluja, Toktam Kianifard, Anuradha Venugopalan, Mihir Gharia
  Cureus.2023;[Epub]     CrossRef
• Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti‐TNF therapy in tuberculosis endemic region
  Peeyush Kumar, Sudheer K. Vuyyuru, Bhaskar Kante, Pabitra Sahu, Sandeep Goyal, Deepak Madhu, Saransh Jain, Mukesh Kumar Ranjan, Sandeep Mundhra, Rithvik Golla, Mukesh Singh, Shubi Virmani, Anvita Gupta, Nidhi Yadav, Mani Kalaivani, Raju Sharma, Prasenjit
  Alimentary Pharmacology & Therapeutics.2022; 55(11): 1431.     CrossRef
• Challenges for biosimilars: focus on rheumatoid arthritis
  Muhammad Safwan Akram, Neelam Pery, Lucy Butler, Muhammad Imtiaz Shafiq, Nayab Batool, Muhammad Fayyaz ur Rehman, Luke G. Grahame-Dunn, Ali K. Yetisen
  Critical Reviews in Biotechnology.2021; 41(1): 121.     CrossRef
• Evaluation of adalimumab biosimilar in treatment of psoriatic arthritis with concomitant moderate to severe chronic plaque psoriasis: An open-labeled, prospective, pilot case series
  Sujay Khandpur, Prateek Sondhi, Neha Taneja, Preeti Sharma, Dayasagar Das, Alpana Sharma, Vishnubatla Sreenivas
  Journal of the American Academy of Dermatology.2020; 83(1): 248.     CrossRef
• Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis
  Saurabh Kedia, Venigalla Pratap Mouli, Nagesh Kamat, Jeeva Sankar, Ashwin Ananthakrishnan, Govind Makharia, Vineet Ahuja
  American Journal of Gastroenterology.2020; 115(3): 340.     CrossRef
• Biosimilars in inflammatory bowel disease
  Saurabh Talathi, Kondal R. Kyanam Kabir Baig
  Journal of Digestive Diseases.2020; 21(11): 610.     CrossRef
• Rapid attainment of target trough concentrations of tacrolimus for early improvement of clinical symptoms in patients with ulcerative colitis
  Yuto Yamada, Yuta Ohno, Takashi Niwa, Hiroko Kato‐Hayashi, Hideki Hayashi, Takashi Ibuka, Hiroshi Araki, Tadashi Sugiyama, Masahito Shimizu, Akio Suzuki
  Journal of Clinical Pharmacy and Therapeutics.2019; 44(3): 409.     CrossRef
• Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study
  Nagesh Kamat, Saurabh Kedia, Uday C. Ghoshal, Abhimanyu Nehra, Govind Makharia, Ajit Sood, Vandana Midha, Varun Gupta, Gourdas Choudhuri, Vineet Ahuja
  Indian Journal of Gastroenterology.2019; 38(1): 44.     CrossRef
• Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?
  Marjorie Argollo, Gionata Fiorino, Daniela Gilardi, Federica Furfaro, Giulia Roda, Laura Loy, Mariangela Allocca, Laurent Peyrin-Biroulet, Silvio Danese
  Current Pharmaceutical Design.2019; 25(1): 7.     CrossRef

Citations

Citations to this article as recorded by  

• Significance of Cytomegalovirus gB Genotypes in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation: Insights from a Single-Centre Investigation
  Tamara Vasiljevic, Marko Jankovic, Ana Tomic, Ida Bakrac, Stefan Radenovic, Danijela Miljanovic, Aleksandra Knezevic, Tanja Jovanovic, Irena Djunic, Milena Todorovic-Balint
  Pharmaceuticals.2024; 17(4): 428.     CrossRef
• Cytomegalovirus Genotype Distribution among Congenital and Perinatal Infected Patients with CMV-Associated Thrombocytopenia
  Hongbo Hu, Wenwen Peng, Qiaoying Peng, Ying Cheng
  Fetal and Pediatric Pathology.2022; 41(1): 77.     CrossRef
• Cytomegalovirus Genotype and Virulence in Infants with Congenital Infection
  Hong-bo Hu, Jian-gang Wu, Jian-jun Sun, Qiao-ying Peng, Xiao-peng Shang
  Journal of Pediatric Infectious Diseases.2021; 16(04): 171.     CrossRef
• Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity
  Hsuan-Yuan Wang, Sarah M. Valencia, Susanne P. Pfeifer, Jeffrey D. Jensen, Timothy F. Kowalik, Sallie R. Permar
  Viruses.2021; 13(6): 1106.     CrossRef
• Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
  Alexandre Jentzer, Pauline Veyrard, Xavier Roblin, Pierre Saint-Sardos, Nicolas Rochereau, Stéphane Paul, Thomas Bourlet, Bruno Pozzetto, Sylvie Pillet
  Microorganisms.2020; 8(7): 1078.     CrossRef

Citations

Citations to this article as recorded by  

• Effect of three modification methods on physical and functional properties of flaxseed cake dietary fiber
  Yanxiong Huo, Yongwang Niu, Saisai Feng, Liangliang Zhang, Jianguo Xu, Qingping Hu
  LWT.2024; 198: 116076.     CrossRef
• Prevotella enterotype associates with diets supporting acidic faecal pH and production of propionic acid by microbiota
  Signe Adamberg, Kaarel Adamberg
  Heliyon.2024; 10(10): e31134.     CrossRef
• Validating a semi-quantitative food frequency questionnaire to assess regional diet in a study of cancer in South West Nigeria
  Marguerite L. Samson, Noah C. Peeri, Olusegun Isaac Alatise, Kelli O’Connell, Avinash Sharma, Samson Gbenga Ogunleye, Adewale A. Aderounmu, Olalekan Olasehinde, Akinjide Olurotimi Ogundokun, Abiodun Victor Ikujenlola, Adesegun Fatusi, T. Peter Kingham, Me
  Cancer Causes & Control.2023; 34(6): 495.     CrossRef
• Experimental Capacity of Human Fecal Microbiota to Degrade Fiber and Produce Short-Chain Fatty Acids Is Associated with Diet Quality and Anthropometric Parameters
  Anna M. Malinowska, Malgorzata Majcher, Guido JEJ. Hooiveld, Hanna Przydatek, Marta Szaban, Agata Kurowiecka, Marcin Schmidt
  The Journal of Nutrition.2023; 153(10): 2827.     CrossRef
• Perioperative Factors Affecting the Healing of Rectovaginal Fistula
  Małgorzata Satora, Klaudia Żak, Karolina Frankowska, Marcin Misiek, Rafał Tarkowski, Marcin Bobiński
  Journal of Clinical Medicine.2023; 12(19): 6421.     CrossRef
• The effects of enzymatic modification on the functional ingredient - Dietary fiber extracted from potato residue
  Qianyun Ma, Ziye Ma, Wenxiu Wang, Jianlou Mu, Yaqiong Liu, Jie Wang, Letitia Stipkovits, Xiaodan Hui, Gang Wu, Jianfeng Sun
  LWT.2022; 153: 112511.     CrossRef
• Dietary Intake and Cancer in Sub-Saharan Africa: A Critical Review of Epidemiological Studies
  Galya Bigman, Linda Otieno, Sally N. Adebamowo, Clement Adebamowo
  Nutrition and Cancer.2022; 74(8): 2803.     CrossRef
• Evaluation of graded levels of corn-fermented protein on stool quality, apparent nutrient digestibility, and palatability in healthy adult cats
  Logan R Kilburn-Kappeler, Krystina A Lema Almeida, Charles G Aldrich
  Journal of Animal Science.2022;[Epub]     CrossRef
• The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries
  Caroline Young, Henry M. Wood, Ramakrishnan Ayloor Seshadri, Pham Van Nang, Carlos Vaccaro, Luis Contreras Melendez, Mayilvahanan Bose, Mai Van Doi, Tamara Alejandra Piñero, Camilo Tapia Valladares, Julieta Arguero, Alba Fuentes Balaguer, Kelsey N. Thomps
  Genome Medicine.2021;[Epub]     CrossRef
• Patterns of Early-Onset Colorectal Cancer Among Nigerians and African Americans
  Andreana N. Holowatyj, Aishatu Suleiman Maude, Halimatu Sadiya Musa, Ahmed Adamu, Sani Ibrahim, Adamu Abdullahi, Muhammad Manko, Sirajo Mohammed Aminu, Abdullahi Mohammed, John Idoko, Yahaya Ukwenya, John Carpten, Paulette D. Chandler, Heather Hampel, Moh
  JCO Global Oncology.2020; (6): 1647.     CrossRef

Citations

Citations to this article as recorded by  

• Usefulness of Stool Multiplex Polymerase Chain Reaction Assays in Patients with Acute Diarrhea
  Seo Hyun Kim, You Sun Kim, Seung Hyuk Kim, Won Eui Yoon, Hee Jun Myung, Jeong Seop Moon, Dong Hee Whang
  The Korean Journal of Gastroenterology.2022; 79(3): 118.     CrossRef
• Persistent Leg Drainage in a Pediatric Trauma Patient
  Ashley Howard, Michelle R. Rychalsky, Thomas S. Murray
  Pediatric Infectious Disease Journal.2021; 40(6): 597.     CrossRef
• Real-Time Detection and Motion Recognition of Human Moving Objects Based on Deep Learning and Multi-Scale Feature Fusion in Video
  Meimei Gong, Yiming Shu
  IEEE Access.2020; 8: 25811.     CrossRef
• Temporal change of risk factors in hospital-acquired Clostridioides difficile infection using time-trend analysis
  Jiyoun Song, Bevin Cohen, Philip Zachariah, Jianfang Liu, Elaine L. Larson
  Infection Control & Hospital Epidemiology.2020; 41(9): 1048.     CrossRef
• Incidence and Characteristics ofClostridioides difficileInfection in Children
  Heera Jeong, Ji-Man Kang, Jong Gyun Ahn
  Pediatric Infection & Vaccine.2020; 27(3): 158.     CrossRef
• RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
  Jung Hoon Song, You Sun Kim
  Gut and Liver.2019; 13(1): 16.     CrossRef
• Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea
  Dae Bum Kim, Kang-Moon Lee, Sang Hyoung Park, You Sun Kim, Eun Soo Kim, Jun Lee, Sung-Ae Jung, Geom Seog Seo, Ji Min Lee
  Intestinal Research.2018; 16(2): 267.     CrossRef

Citations

Citations to this article as recorded by  

• Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colon
  Jayati Sarangi, Prasenjit Das, Aijaz Ahmad, Mohamed Sulaiman, Shouriyo Ghosh, Brijnandan Gupta, Rajesh Panwar, Sujoy Pal, Rajni Yadav, Vineet Ahuja, Sudip Sen, Asish D. Upadhyay, Nihar R. Dash, Atul Sharma, Siddhartha D. Gupta
  Journal of Cancer Research and Therapeutics.2024; 20(1): 268.     CrossRef

Citations

Citations to this article as recorded by  

• When should patients take simethicone orally before colonoscopy for avoiding bubbles: A single-blind, randomized controlled study
  Woohyuk Jung, Gyu Man Oh, Jae Hyun Kim, Youn Jung Choi, Min Young Son, Kyoungwon Jung, Sung Eun Kim, Won Moon, Moo In Park, Seun Ja Park
  Medicine.2023; 102(19): e33728.     CrossRef
• Comparison of the efficacy and safety between oral sulfate tablet and polyethylene glycol for bowel preparation before colonoscopy according to age
  Jae Hyun Kim, Yong Eun Park, Tae Oh Kim, Jongha Park, Gyu Man Oh, Won Moon, Seun Ja Park
  Medicine.2022; 101(27): e29884.     CrossRef
• Optimization of the surveillance strategy in patients with colorectal adenomas: A combination of clinical parameters and index colonoscopy findings
  Chan Hyuk Park, Yoon Suk Jung, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn
  Journal of Gastroenterology and Hepatology.2021; 36(4): 974.     CrossRef
• Postgastrectomy gastric cancer patients are at high risk for colorectal neoplasia: a case control study
  Tae-Geun Gweon, Kyu-Tae Yoon, Chang Hyun Kim, Jin-Jo Kim
  Intestinal Research.2021; 19(2): 239.     CrossRef
• Risk of developing metachronous advanced colorectal neoplasia after resection of low-risk diminutive versus small adenomas
  Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn
  Gastrointestinal Endoscopy.2020; 91(3): 622.     CrossRef
• Optimal Colonoscopic Surveillance Interval After Normal Baseline Screening Colonoscopy
  Jian Dong, Minman Wu, Jiarong Miao, Rana Sami Ullah Khan, Tao Zhi, Tianmei Zhang, Xue Li, Yashi Peng, Gang Yang, Qiong Nan
  Gastroenterology Nursing.2020; 43(3): 225.     CrossRef
• Comparative systematic review and meta-analysis of 1- to 5-mm versus 6- to 9-mm adenomas on the risk of metachronous advanced colorectal neoplasia
  Yoon Suk Jung, Tae Jun Kim, Eunwoo Nam, Chan Hyuk Park
  Gastrointestinal Endoscopy.2020; 92(3): 692.     CrossRef
• Appropriate Surveillance Interval after Colonoscopic Polypectomy in Patients Younger than 50 Years
  Yoon Suk Jung, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn
  Journal of Korean Medical Science.2019;[Epub]     CrossRef
• Impact of obesity and metabolic abnormalities on the risk of metachronous colorectal neoplasia after polypectomy in men
  Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn
  Journal of Gastroenterology and Hepatology.2019; 34(9): 1504.     CrossRef
• What Is Appropriate Upper Endoscopic Interval Among Dyspeptic Patients With Previously Normal Endoscopy? A Multicenter Study With Bayesian Change Point Analysis
  Jong Wook Kim, Kee Wook Jung, Joong Goo Kwon, Jung Bok Lee, Jong Kyu Park, Ki Bae Bang, Chung Hyun Tae, Jung Hwan Oh
  Journal of Neurogastroenterology and Motility.2019; 25(4): 544.     CrossRef
• Risk of Developing Metachronous Advanced Colorectal Neoplasia After Polypectomy in Patients With Multiple Diminutive or Small Adenomas
  Nam Hee Kim, Yoon Suk Jung, Mi Yeon Lee, Jung Ho Park, Dong Il Park, Chong Il Sohn
  American Journal of Gastroenterology.2019; 114(10): 1657.     CrossRef

Citations

Citations to this article as recorded by  

• Endoscopic Diagnosis, Treatment, and Follow-up of Serrated Polyps
  Duk Hwan Kim
  Journal of Digestive Cancer Research.2023; 11(1): 30.     CrossRef
• Features associated with high‐risk sessile serrated polyps at index and follow‐up colonoscopy
  Shahzaib Anwar, Charles Cock, Joanne Young, Graeme P Young, Rosie Meng, Kalindra Simpson, Michelle Coats, Junming Huang, Peter Bampton, Robert Fraser, Erin L Symonds
  Journal of Gastroenterology and Hepatology.2021; 36(6): 1620.     CrossRef
• Descriptive epidemiological study of South African colorectal cancer patients at a Johannesburg Hospital Academic institution
  Michelle McCabe, Yvonne Perner, Rindidzani Magobo, Sheefa Mirza, Clement Penny
  JGH Open.2020; 4(3): 360.     CrossRef
• Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia
  Xinwei Hua, Polly A. Newcomb, Jessica Chubak, Rachel C. Malen, Rebecca Ziebell, Aruna Kamineni, Lee-Ching Zhu, Melissa P. Upton, Michelle A. Wurscher, Sushma S. Thomas, Hana Newman, Sheetal Hardikar, Andrea N. Burnett-Hartman
  Cancer Causes & Control.2020; 31(7): 631.     CrossRef
• The association between colorectal sessile serrated adenomas/polyps and subsequent advanced colorectal neoplasia
  Andrea N. Burnett-Hartman, Jessica Chubak, Xinwei Hua, Rebecca Ziebell, Aruna Kamineni, Lee-Ching Zhu, Melissa P. Upton, Rachel C. Malen, Sheetal Hardikar, Polly A. Newcomb
  Cancer Causes & Control.2019; 30(9): 979.     CrossRef
• Surveillance colonoscopy in patients with sessile serrated adenoma
  Ji Hyung Nam, Hyoun Woo Kang
  Intestinal Research.2018; 16(3): 502.     CrossRef

Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.

Citations

Citations to this article as recorded by  

• Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent Clostridioides difficile Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study
  Jing-Han Chen, Cheng-Hsun Chiu, Chien-Chang Chen, Yi-Ching Chen, Pai-Jui Yeh, Chia-Jung Kuo, Cheng-Tang Chiu, Hao-Tsai Cheng, Yu-Bin Pan, Puo-Hsien Le
  Biomedicines.2024; 12(7): 1396.     CrossRef
• The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
  Loris Riccardo Lopetuso, Sara Deleu, Lihi Godny, Valentina Petito, Pierluigi Puca, Federica Facciotti, Harry Sokol, Gianluca Ianiro, Luca Masucci, Maria Abreu, Iris Dotan, Samuel Paul Costello, Ailsa Hart, Tariq H Iqbal, Sudarshan Paramsothy, Maurizio San
  Gut.2023; 72(9): 1642.     CrossRef
• Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome
  Kazuyoshi Gotoh, Yoshihiko Sakaguchi, Haru Kato, Hayato Osaki, Yasutaka Jodai, Mitsutaka Wakuda, Akira Také, Shunji Hayashi, Eri Morita, Takehiko Sugie, Yoichiro Ito, Naoki Ohmiya
  Anaerobe.2022; 73: 102502.     CrossRef
• Management of Clostridioides difficile infection in patients with inflammatory bowel disease
  Sahil Khanna
  Intestinal Research.2021; 19(3): 265.     CrossRef
• Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
  Xiao Yan Guo, Xin Juan Liu, Jian Yu Hao
  Journal of Digestive Diseases.2020; 21(3): 147.     CrossRef
• RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
  Jung Hoon Song, You Sun Kim
  Gut and Liver.2019; 13(1): 16.     CrossRef
• Current Status of Clostridium Difficile Infection
  Akira Andoh, Shigeki Bamba
  Nippon Daicho Komonbyo Gakkai Zasshi.2018; 71(10): 456.     CrossRef

Pemphigus vulgaris is an autoimmune bullous disorder characterized by the production of autoantibodies against the intercellular space of the epithelium. It has rarely been reported in association with inflammatory bowel disease. Ulcerative colitis is one of the forms of inflammatory bowel disease. A 62-year-old woman who had been treated for ulcerative colitis for 16 years developed pruritic bullae on the skin of her face and body. Histological findings and direct immunofluorescence examination of the skin showed pemphigus vulgaris. She was treated with systemic steroids, mesalazine, and azathioprine. Her cutaneous lesions have remained in remission and her ulcerative colitis has remained well-controlled. The relationship between pemphigus vulgaris and ulcerative colitis is unclear. An autoimmune response has been suspected in the pathogenesis of ulcerative colitis. Pemphigus vulgaris is also associated with an autoimmune mechanism. To our knowledge, this is the first case of ulcerative colitis associated with pemphigus vulgaris reported in Korea. The association may be causal.

Citations

Citations to this article as recorded by  

• Persistent Scattered Pustules: Vesiculopustular IgA Pemphigus Arising in a Patient With Ulcerative Colitis
  Melissa M. Warne, Matthew F. Helm, Andrew Gaddi, Raminder Grover
  The American Journal of Dermatopathology.2023; 45(5): 350.     CrossRef
• Cell-Matrix Interactions Contribute to Barrier Function in Human Colon Organoids
  James Varani, Shannon D. McClintock, Muhammad N. Aslam
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview
  Kyla Pagani, Danitza Lukac, Aashni Bhukhan, Jean S. McGee
  American Journal of Clinical Dermatology.2022; 23(4): 481.     CrossRef
• Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review
  Heng L. Tham, Keith E. Linder, Thierry Olivry
  BMC Veterinary Research.2020;[Epub]     CrossRef

Amyloidosis is defined as the extracellular deposition of non-branching fibrils composed of a variety of serum-protein precursors. Secondary amyloidosis is associated with several chronic inflammatory conditions, such as rheumatologic or intestinal diseases, familial Mediterranean fever, or chronic infectious diseases, such as tuberculosis. Although the association of amyloidosis with inflammatory bowel disease is known, amyloidosis secondary to ulcerative colitis (UC) is rare. A 36-year-old male patient with a 15-year history of UC presented with nausea, vomiting, and abdominal pain. He had been treated with infliximab for 6 years. At the time of admission, he had been undergoing treatment with mesalazine and adalimumab since the preceding 5 months. Esophagogastroduodenoscopy showed mucosal erythema, edema, and erosions with geographic ulcers at the 2nd and 3rd portions of the duodenum. Duodenal amyloidosis was diagnosed using polarized light microscopy and Congo red stain. Monoclonal gammopathy was not detected in serum and urine tests, while the serum free light chain assay result was not specific. An increase in plasma cells in the bone marrow was not found. Secondary amyloidosis due to UC was suspected. The symptoms were resolved after glucocorticoid therapy.

Citations

Citations to this article as recorded by  

• Gastrointestinal amyloidosis in a 50‐year‐old patient with miliary tuberculosis: A case report
  Sameer Abdul Rauf, Hussain Haider Shah, Rahul Khatri, Mansoor Ul Haq, Tirth Dave, Javaria Parwez Ali, Syed Khizar Ali
  Clinical Case Reports.2024;[Epub]     CrossRef
• Therapeutic effects of biological treatments on AA amyloidosis associated with inflammatory bowel disease: a case report and literature review
  Marouf Alhalabi, Kamal Alaa Eddin, Ahmad Abbas
  European Journal of Gastroenterology & Hepatology.2023; 35(11): 1298.     CrossRef
• Rheumatoid arthritis: Extra-articular manifestations and comorbidities
  Fabiana Assunta Figus, Matteo Piga, Irene Azzolin, Rebecca McConnell, Annamaria Iagnocco
  Autoimmunity Reviews.2021; 20(4): 102776.     CrossRef
• Specific Clinical and Morphological Characteristics of Amyloidosis of the Stomach and Duodenum
  Z. V. Gioeva, L. M. Mikhaleva
  Journal of Anatomy and Histopathology.2019; 8(1): 39.     CrossRef
• Morphological and Immunohistochemical Characteristics of Experimental Mandibular Fractures Healing Process
  A. A. Matchin, A. A. Stadnikov, E. V. Nosov, S. Kh. Kiriakidi
  Journal of Anatomy and Histopathology.2019; 8(1): 44.     CrossRef
• Secondary, AA, Amyloidosis
  Riccardo Papa, Helen J. Lachmann
  Rheumatic Disease Clinics of North America.2018; 44(4): 585.     CrossRef

Pyoderma gangrenosum (PG), an ulcerating skin condition, is rare in patients with ulcerative colitis (UC). We report a case of successful treatment of PG in a patient with UC using hyperbaric oxygen therapy (HBOT). The patient had UC that was in remission following treatment with mesalazine and azathioprine therapy. After visiting an orthopedic clinic, the patient opted for treatment with antibiotics and daily dressing of the ulcerative skin lesions, while azathioprine was discontinued. However, the lesions did not improve. Two months later, the patient visited a dermatologist who diagnosed the lesions as PG, and he was admitted to our unit. Surgical debridement and HBOT were performed by a plastic surgeon in the emergency department. After 3 months of HBOT and topical treatment, the patient's PG completely resolved. His UC was still in remission with mesalazine alone. HBOT may be an effective and safe alternative treatment for PG associated with UC, particularly in patients in whom anti-tumor necrosis factor agents are unnecessary.

Citations

Citations to this article as recorded by  

• The new insights of hyperbaric oxygen therapy: focus on inflammatory bowel disease
  Leilei Chen, Yan Wang, Huihui Zhou, Yi Liang, Fengqin Zhu, Guangxi Zhou
  Precision Clinical Medicine.2024;[Epub]     CrossRef
• Emerging Indications for Hyperbaric Oxygen Treatment: Registry Cohort Study
  Hideaki L Tanaka, Judy R Rees, Ziyin Zhang, Judy A Ptak, Pamela M Hannigan, Elaine M Silverman, Janet L Peacock, Jay C Buckey
  Interactive Journal of Medical Research.2024; 13: e53821.     CrossRef
• EFICÁCIA DA OXIGENOTERAPIA HIPERBÁRICA NO TRATAMENTO DE PIODERMA GANGRENOSO
  Ana Júllia Almeida Ferreira, Natally Macedo Torrente, Pedro Paulo Custódio Martinez Sacchi, Poliana Pezzotto
  RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218.2024; 5(9): e595755.     CrossRef
• Treatment of Pyoderma Gangrenosum With Mycophenolate and Hyperbaric Oxygen Therapy: A Case Report and Literature Review
  Subo Dey, Nirali Sanghavi, Amy Wasserman, Kausik Kar
  Cureus.2023;[Epub]     CrossRef
• Efficacy and safety evaluation of hyperbaric oxygen therapy for patients with ulcerative colitis
  Wei Wang, Ying He, Dou Wen, Shangshang Jiang, Xiaodong Zhao
  Medicine.2021; 100(1): e23966.     CrossRef
• Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn’s Disease: An Observational Study
  Marley R. Feitosa, Rogério S. Parra, Vanessa F. Machado, Gustavo N. Vilar, Jussara C. Aquino, José J. R. Rocha, Paulo G. Kotze, Omar Féres, Chiara Ricci
  Gastroenterology Research and Practice.2021; 2021: 1.     CrossRef
• The role of hyperbaric oxygen therapy in inflammatory bowel disease
  Xin Wu, Tian-Yu Liang, Zhong Wang, Gang Chen
  Medical Gas Research.2021; 11(2): 66.     CrossRef
• Giant pyoderma gangrenosum in a patient with ulcerative colitis
  Ruixian Niu, Jiangtao Zheng, Dongmei Ding, Weian Kuang, Fengyan Lu, Xunguo Yin
  Medicine.2020; 99(6): e18795.     CrossRef
• Development of an International, Multicenter, Hyperbaric Oxygen Treatment Registry and Research Consortium: Protocol for Outcome Data Collection and Analysis
  Nicole P Harlan, Judy A Ptak, Judy R Rees, Devin R Cowan, Abigail M Fellows, Judith A Kertis, Pamela M Hannigan, Janet L Peacock, Jay C Buckey
  JMIR Research Protocols.2020; 9(8): e18857.     CrossRef
• Post-surgical pyoderma gangrenosum of the breast: needs for early diagnosis and right therapy
  Giorgia Guaitoli, Federico Piacentini, Claudia Omarini, Alessia Andreotti, Enza Palma, Simona Papi, Chiara De Pietri, Andrea Conti, Stefano Cascinu, Giovanni Tazzioli
  Breast Cancer.2019; 26(4): 520.     CrossRef
• Atypical wounds. Best clinical practice and challenges
  Kirsi Isoherranen, Julie Jordan O'Brien, Judith Barker, Joachim Dissemond, Jürg Hafner, Gregor B. E. Jemec, Jivko Kamarachev, Severin Läuchli, Elena Conde Montero, Stephan Nobbe, Cord Sunderkötter, Mar Llamas Velasco
  Journal of Wound Care.2019; 28(Sup6): S1.     CrossRef
• Pyoderma Gangrenosum: What Do We Know Now?
  Fatima McKenzie, Megan Arthur, Alex G. Ortega-Loayza
  Current Dermatology Reports.2018; 7(3): 147.     CrossRef
• Pyoderma gangrenosum – an interdisciplinary approach to the disease
  Aleksandra Kapuśniak, Aleksandra Czachor, Grażyna Wąsik
  Medical Science Pulse.2018; 12(4): 61.     CrossRef

Citations

Citations to this article as recorded by  

• Inflammatory bowel disease in Korea: epidemiology and pathophysiology
  Jung Won Lee, Chang Soo Eun
  The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef